1
|
Beau A, Benoit B, Le Barz M, Meugnier E, Penhoat A, Calzada C, Pinteur C, Loizon E, Chanon S, Vieille-Marchiset A, Sauvinet V, Godet M, Laugerette F, Holowacz S, Jacouton E, Michalski MC, Vidal H. Inhibition of intestinal FXR activity as a possible mechanism for the beneficial effects of a probiotic mix supplementation on lipid metabolism alterations and weight gain in mice fed a high fat diet. Gut Microbes 2023; 15:2281015. [PMID: 37985749 PMCID: PMC10730200 DOI: 10.1080/19490976.2023.2281015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/20/2023] [Accepted: 11/05/2023] [Indexed: 11/22/2023] Open
Abstract
Supplementation with probiotics has emerged as a promising therapeutic tool to manage metabolic diseases. We investigated the effects of a mix of Bifidobacterium animalis subsp. lactis LA804 and Lactobacillus gasseri LA806 on high-fat (HF) diet -induced metabolic disease in mice. Supplementation with the probiotic mix in HF diet-fed mice (HF-Pr2) reduced weight and fat mass gains, decreased hepatic lipid accumulation, and lowered plasma triglyceride peak during an oral lipid tolerance test. At the molecular level, the probiotic mix protected against HF-induced rise in mRNA levels of genes related to lipid uptake, metabolism, and storage in the liver and white adipose tissues, and strongly decreased mRNA levels of genes related to inflammation in the white adipose tissue and to oxidative stress in the liver. Regarding intestinal homeostasis, the probiotic mix did not prevent HF-induced gut permeability but slightly modified microbiota composition without correcting the dysbiosis induced by the HF diet. Probiotic supplementation also modified the cecal bile acid (BA) profile, leading to an increase in the Farnesoid-X-Receptor (FXR) antagonist/agonist ratio between BA species. In agreement, HF-Pr2 mice exhibited a strong inhibition of FXR signaling pathway in the ileum, which was associated with lipid metabolism protection. This is consistent with recent reports proposing that inhibition of intestinal FXR activity could be a potent mechanism to overcome metabolic disorders. Altogether, our results demonstrate that the probiotic mix evaluated, when administered preventively to HF diet-fed mice could limit obesity and associated lipid metabolism disorders, likely through the inhibition of FXR signaling in the intestinal tract.
Collapse
Affiliation(s)
- Alice Beau
- Laboratoire CarMeN, INSERM U.1060, INRAe U. 1397, Université Claude Bernard Lyon1, Pierre Bénite, France
| | - Bérengère Benoit
- Laboratoire CarMeN, INSERM U.1060, INRAe U. 1397, Université Claude Bernard Lyon1, Pierre Bénite, France
| | - Mélanie Le Barz
- Laboratoire CarMeN, INSERM U.1060, INRAe U. 1397, Université Claude Bernard Lyon1, Pierre Bénite, France
| | - Emmanuelle Meugnier
- Laboratoire CarMeN, INSERM U.1060, INRAe U. 1397, Université Claude Bernard Lyon1, Pierre Bénite, France
| | - Armelle Penhoat
- Laboratoire CarMeN, INSERM U.1060, INRAe U. 1397, Université Claude Bernard Lyon1, Pierre Bénite, France
| | - Catherine Calzada
- Laboratoire CarMeN, INSERM U.1060, INRAe U. 1397, Université Claude Bernard Lyon1, Pierre Bénite, France
| | - Claudie Pinteur
- Laboratoire CarMeN, INSERM U.1060, INRAe U. 1397, Université Claude Bernard Lyon1, Pierre Bénite, France
| | - Emmanuelle Loizon
- Laboratoire CarMeN, INSERM U.1060, INRAe U. 1397, Université Claude Bernard Lyon1, Pierre Bénite, France
| | - Stéphanie Chanon
- Laboratoire CarMeN, INSERM U.1060, INRAe U. 1397, Université Claude Bernard Lyon1, Pierre Bénite, France
| | - Aurélie Vieille-Marchiset
- Laboratoire CarMeN, INSERM U.1060, INRAe U. 1397, Université Claude Bernard Lyon1, Pierre Bénite, France
| | - Valérie Sauvinet
- Centre de Recherche en Nutrition Humaine - Rhône-Alpes, INSERM, INRAe, Université Claude Bernard Lyon1, Hospices Civils de Lyon, Pierre Bénite, France
| | - Murielle Godet
- Laboratoire CarMeN, INSERM U.1060, INRAe U. 1397, Université Claude Bernard Lyon1, Pierre Bénite, France
| | - Fabienne Laugerette
- Laboratoire CarMeN, INSERM U.1060, INRAe U. 1397, Université Claude Bernard Lyon1, Pierre Bénite, France
| | - Sophie Holowacz
- Research & Development Department, PiLeJe Laboratoire, Paris, France
| | - Elsa Jacouton
- Research & Development Department, PiLeJe Laboratoire, Paris, France
| | - Marie-Caroline Michalski
- Laboratoire CarMeN, INSERM U.1060, INRAe U. 1397, Université Claude Bernard Lyon1, Pierre Bénite, France
- Centre de Recherche en Nutrition Humaine - Rhône-Alpes, INSERM, INRAe, Université Claude Bernard Lyon1, Hospices Civils de Lyon, Pierre Bénite, France
| | - Hubert Vidal
- Laboratoire CarMeN, INSERM U.1060, INRAe U. 1397, Université Claude Bernard Lyon1, Pierre Bénite, France
- Centre de Recherche en Nutrition Humaine - Rhône-Alpes, INSERM, INRAe, Université Claude Bernard Lyon1, Hospices Civils de Lyon, Pierre Bénite, France
| |
Collapse
|
2
|
Delage P, Ségrestin B, Seyssel K, Chanon S, Vieille-Marchiset A, Durand A, Nemeth A, Métairon S, Charpagne A, Descombes P, Hager J, Laville M, Vidal H, Meugnier E. Adipose tissue angiogenesis genes are down-regulated by grape polyphenols supplementation during a human overfeeding trial. J Nutr Biochem 2023; 117:109334. [PMID: 36965784 DOI: 10.1016/j.jnutbio.2023.109334] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2022] [Revised: 01/16/2023] [Accepted: 03/18/2023] [Indexed: 03/27/2023]
Abstract
The adaptive response to overfeeding is associated with profound modifications of gene expression in adipose tissue to support lipid storage and weight gain. The objective of this study was to assess in healthy lean men whether a supplementation with polyphenols could interact with these molecular adaptations. Abdominal subcutaneous adipose tissue biopsies were sampled from 42 subjects participating to an overfeeding protocol providing an excess of 50% of their total energy expenditure for 31 days, and who were supplemented with 2 g/day of grape polyphenols or a placebo. Gene expression profiling was performed by RNA sequencing. Overfeeding led to a modification of the expression of 163 and 352 genes in the placebo and polyphenol groups, respectively. The GO functions of these genes were mostly involved in lipid metabolism, followed by genes involved in adipose tissue remodeling and expansion. In response to overfeeding, 812 genes were differentially regulated between groups. Among them, a set of 41 genes were related to angiogenesis and were downregulated in the polyphenol group. Immunohistochemistry targeting PECAM1, as endothelial cell marker, confirmed reduced angiogenesis in this group. Finally, quercetin and isorhamnetin, two polyphenol species enriched in the plasma of the volunteers submitted to the polyphenols, were found to inhibit human umbilical vein endothelial cells migration in vitro. Polyphenol supplementation do not prevent the regulation of genes related to lipid metabolism in human adipose tissue during overfeeding, but impact the angiogenesis pathways. This may potentially contribute to a protection against adipose tissue expansion during dynamic phase of weight gain.
Collapse
Affiliation(s)
- Pauline Delage
- CarMeN Laboratory, INSERM, INRAe, Claude Bernard Lyon 1 University, Pierre-Bénite, F-69310, France.
| | - Bérénice Ségrestin
- CarMeN Laboratory, INSERM, INRAe, Claude Bernard Lyon 1 University, Pierre-Bénite, F-69310, France; CRNH-RA, INSERM, INRAe, Claude Bernard Lyon 1 University, Hospices Civils de Lyon, Pierre-Bénite, F-69310, France; Centre Hospitalier Lyon-Sud, Service d'Endocrinologie Diabète Nutrition Lyon, Hospices Civils de Lyon, Pierre-Bénite, F-69100, France.
| | - Kévin Seyssel
- CarMeN Laboratory, INSERM, INRAe, Claude Bernard Lyon 1 University, Pierre-Bénite, F-69310, France; CRNH-RA, INSERM, INRAe, Claude Bernard Lyon 1 University, Hospices Civils de Lyon, Pierre-Bénite, F-69310, France.
| | - Stéphanie Chanon
- CarMeN Laboratory, INSERM, INRAe, Claude Bernard Lyon 1 University, Pierre-Bénite, F-69310, France.
| | | | - Annie Durand
- CarMeN Laboratory, INSERM, INRAe, Claude Bernard Lyon 1 University, Pierre-Bénite, F-69310, France.
| | - Angéline Nemeth
- CNRS, INSERM, CREATIS, Université de Lyon, INSA-Lyon, Claude Bernard Lyon 1 University, UJM-Saint Etienne, Lyon, France.
| | | | - Aline Charpagne
- Nestlé Research, EPFL Innovation Park, H, Lausanne, Switzerland.
| | | | - Jörg Hager
- Nestlé Research, EPFL Innovation Park, H, Lausanne, Switzerland.
| | - Martine Laville
- CarMeN Laboratory, INSERM, INRAe, Claude Bernard Lyon 1 University, Pierre-Bénite, F-69310, France; CRNH-RA, INSERM, INRAe, Claude Bernard Lyon 1 University, Hospices Civils de Lyon, Pierre-Bénite, F-69310, France; Centre Hospitalier Lyon-Sud, Service d'Endocrinologie Diabète Nutrition Lyon, Hospices Civils de Lyon, Pierre-Bénite, F-69100, France.
| | - Hubert Vidal
- CarMeN Laboratory, INSERM, INRAe, Claude Bernard Lyon 1 University, Pierre-Bénite, F-69310, France; CRNH-RA, INSERM, INRAe, Claude Bernard Lyon 1 University, Hospices Civils de Lyon, Pierre-Bénite, F-69310, France.
| | - Emmanuelle Meugnier
- CarMeN Laboratory, INSERM, INRAe, Claude Bernard Lyon 1 University, Pierre-Bénite, F-69310, France.
| |
Collapse
|
3
|
Buisson C, Leuzy V, Loizon E, Meugnier E, Monnoye M, Philippe C, Gérard P, Michalski MC, Laugerette F. Soy Lecithin in High-Fat Diets Exerts Dual Effects on Adipose Tissue Versus Ileum. Mol Nutr Food Res 2023; 67:e2200461. [PMID: 36708587 DOI: 10.1002/mnfr.202200461] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2022] [Revised: 01/10/2023] [Indexed: 01/30/2023]
Abstract
SCOPE Lipopolysaccharides and their transporters, LBP and sCD14, are involved in systemic inflammation following a high-fat diet. Natural emulsifiers such as soy lecithin, rich in soybean polar lipids (SPL), are often used by the food industry but little is known about effects of associating SPL with different oils. METHODS AND RESULTS Thus, this study investigates the effects of 4 weeks feeding of palm (P) or rapeseed (R) oil-enriched diets with or without SPL in mice, on white adipose tissue (WAT) inflammation, on ileum permeability, and on microbiota composition. When SPL are associated with rapeseed oil, a greater gene expression of leptin and inflammation in WAT is observed compared to P-SPL. In ileum, R-SPL group results in a lower expression of TLR4, IAP that detoxify bacterial LPS and tight junction proteins than R group. In turn, the gene expression of Reg3β and Reg3γ, which have antimicrobial activity, is higher in ileum of R-SPL group than in R group. SPL in rapeseed oil increases specific bacterial species belonging to Lachnospiraceae, Alistipes, and Bacteroidales. CONCLUSION The incorporation of SPL in a diet with rapeseed oil exerts differential effect on WAT and ileum, with respectively an inflammation of WAT and an antimicrobial activity in ileum, associated with specific microbiota changes.
Collapse
Affiliation(s)
- Charline Buisson
- Univ Lyon, CarMeN laboratory INRAE, UMR1397, INSERM, U1060, Université Claude Bernard Lyon 1, Pierre Bénite, 69310, France
| | - Valentin Leuzy
- Univ Lyon, CarMeN laboratory INRAE, UMR1397, INSERM, U1060, Université Claude Bernard Lyon 1, Pierre Bénite, 69310, France
| | - Emmanuelle Loizon
- Univ Lyon, CarMeN laboratory INRAE, UMR1397, INSERM, U1060, Université Claude Bernard Lyon 1, Pierre Bénite, 69310, France
| | - Emmanuelle Meugnier
- Univ Lyon, CarMeN laboratory INRAE, UMR1397, INSERM, U1060, Université Claude Bernard Lyon 1, Pierre Bénite, 69310, France
| | - Magali Monnoye
- Micalis Institute, Université Paris-Saclay, INRAE, AgroParisTech, Jouy-en-Josas, 78350, France
| | - Catherine Philippe
- Micalis Institute, Université Paris-Saclay, INRAE, AgroParisTech, Jouy-en-Josas, 78350, France
| | - Philippe Gérard
- Micalis Institute, Université Paris-Saclay, INRAE, AgroParisTech, Jouy-en-Josas, 78350, France
| | - Marie-Caroline Michalski
- Univ Lyon, CarMeN laboratory INRAE, UMR1397, INSERM, U1060, Université Claude Bernard Lyon 1, Pierre Bénite, 69310, France.,CRNH Rhône-Alpes, Oullins, 69310, France
| | - Fabienne Laugerette
- Univ Lyon, CarMeN laboratory INRAE, UMR1397, INSERM, U1060, Université Claude Bernard Lyon 1, Pierre Bénite, 69310, France
| |
Collapse
|
4
|
Salles J, Chanet A, Guillet C, Vaes AMM, Brouwer-Brolsma EM, Rocher C, Giraudet C, Patrac V, Meugnier E, Montaurier C, Denis P, Le Bacquer O, Blot A, Jourdan M, Luiking Y, Furber M, Van Dijk M, Tardif N, Yves Boirie Y, Walrand S. Vitamin D status modulates mitochondrial oxidative capacities in skeletal muscle: role in sarcopenia. Commun Biol 2022; 5:1288. [PMID: 36434267 PMCID: PMC9700804 DOI: 10.1038/s42003-022-04246-3] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2022] [Accepted: 11/10/2022] [Indexed: 11/27/2022] Open
Abstract
Skeletal muscle mitochondrial function is the biggest component of whole-body energy output. Mitochondrial energy production during exercise is impaired in vitamin D-deficient subjects. In cultured myotubes, loss of vitamin D receptor (VDR) function decreases mitochondrial respiration rate and ATP production from oxidative phosphorylation. We aimed to examine the effects of vitamin D deficiency and supplementation on whole-body energy expenditure and muscle mitochondrial function in old rats, old mice, and human subjects. To gain further insight into the mechanisms involved, we used C2C12 and human muscle cells and transgenic mice with muscle-specific VDR tamoxifen-inducible deficiency. We observed that in vivo and in vitro vitamin D fluctuations changed mitochondrial biogenesis and oxidative activity in skeletal muscle. Vitamin D supplementation initiated in older people improved muscle mass and strength. We hypothesize that vitamin D supplementation is likely to help prevent not only sarcopenia but also sarcopenic obesity in vitamin D-deficient subjects.
Collapse
Affiliation(s)
- Jérôme Salles
- grid.494717.80000000115480420Université Clermont Auvergne, INRAE, UNH, CRNH Auvergne, 63000 Clermont-Ferrand, France
| | - Audrey Chanet
- grid.494717.80000000115480420Université Clermont Auvergne, INRAE, UNH, CRNH Auvergne, 63000 Clermont-Ferrand, France
| | - Christelle Guillet
- grid.494717.80000000115480420Université Clermont Auvergne, INRAE, UNH, CRNH Auvergne, 63000 Clermont-Ferrand, France
| | - Anouk MM. Vaes
- grid.4818.50000 0001 0791 5666Wageningen University, Human Nutrition, Wageningen, the Netherlands
| | - Elske M. Brouwer-Brolsma
- grid.4818.50000 0001 0791 5666Wageningen University, Human Nutrition, Wageningen, the Netherlands
| | - Christophe Rocher
- grid.412041.20000 0001 2106 639XLaboratoire de Biogenèse Membranaire - UMR 5200 CNRS, Université de Bordeaux, 33140 Villenave d’Ornon, France
| | - Christophe Giraudet
- grid.494717.80000000115480420Université Clermont Auvergne, INRAE, UNH, CRNH Auvergne, 63000 Clermont-Ferrand, France
| | - Véronique Patrac
- grid.494717.80000000115480420Université Clermont Auvergne, INRAE, UNH, CRNH Auvergne, 63000 Clermont-Ferrand, France
| | - Emmanuelle Meugnier
- Univ Lyon, CarMeN Laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, 69310 Pierre-Bénite, France
| | - Christophe Montaurier
- grid.494717.80000000115480420Université Clermont Auvergne, INRAE, UNH, CRNH Auvergne, 63000 Clermont-Ferrand, France
| | - Philippe Denis
- grid.494717.80000000115480420Université Clermont Auvergne, INRAE, UNH, CRNH Auvergne, 63000 Clermont-Ferrand, France
| | - Olivier Le Bacquer
- grid.494717.80000000115480420Université Clermont Auvergne, INRAE, UNH, CRNH Auvergne, 63000 Clermont-Ferrand, France
| | - Adeline Blot
- grid.411163.00000 0004 0639 4151CHU Clermont-Ferrand, Centre de Recherche en Nutrition Humaine Auvergne, 63000 Clermont-Ferrand, France
| | - Marion Jourdan
- grid.468395.50000 0004 4675 6663Specialized Nutrition, Danone Nutricia Research, P.O. Box 80141, 3584 CT Utrecht, the Netherlands
| | - Yvette Luiking
- grid.468395.50000 0004 4675 6663Specialized Nutrition, Danone Nutricia Research, P.O. Box 80141, 3584 CT Utrecht, the Netherlands
| | - Matthew Furber
- grid.468395.50000 0004 4675 6663Specialized Nutrition, Danone Nutricia Research, P.O. Box 80141, 3584 CT Utrecht, the Netherlands
| | - Miriam Van Dijk
- grid.468395.50000 0004 4675 6663Specialized Nutrition, Danone Nutricia Research, P.O. Box 80141, 3584 CT Utrecht, the Netherlands
| | - Nicolas Tardif
- grid.24381.3c0000 0000 9241 5705Division of Perioperative Medicine and Intensive Care, Karolinska University Hospital, Huddinge, Sweden
| | - Y. Yves Boirie
- grid.494717.80000000115480420Université Clermont Auvergne, INRAE, UNH, CRNH Auvergne, 63000 Clermont-Ferrand, France ,grid.411163.00000 0004 0639 4151CHU Clermont-Ferrand, Service Nutrition Clinique, 63000 Clermont-Ferrand, France
| | - Stéphane Walrand
- grid.494717.80000000115480420Université Clermont Auvergne, INRAE, UNH, CRNH Auvergne, 63000 Clermont-Ferrand, France ,grid.411163.00000 0004 0639 4151CHU Clermont-Ferrand, Service Nutrition Clinique, 63000 Clermont-Ferrand, France
| |
Collapse
|
5
|
Bartova S, Madrid-Gambin F, Fernández L, Carayol J, Meugnier E, Segrestin B, Delage P, Vionnet N, Boizot A, Laville M, Vidal H, Marco S, Hager J, Moco S. Grape polyphenols decrease circulating branched chain amino acids in overfed adults. Front Nutr 2022; 9:998044. [PMID: 36386937 PMCID: PMC9643885 DOI: 10.3389/fnut.2022.998044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2022] [Accepted: 10/10/2022] [Indexed: 12/02/2022] Open
Abstract
Introduction and aims Dietary polyphenols have long been associated with health benefits, including the prevention of obesity and related chronic diseases. Overfeeding was shown to rapidly induce weight gain and fat mass, associated with mild insulin resistance in humans, and thus represents a suitable model of the metabolic complications resulting from obesity. We studied the effects of a polyphenol-rich grape extract supplementation on the plasma metabolome during an overfeeding intervention in adults, in two randomized parallel controlled clinical trials. Methods Blood plasma samples from 40 normal weight to overweight male adults, submitted to a 31-day overfeeding (additional 50% of energy requirement by a high calorie-high fructose diet), given either 2 g/day grape polyphenol extract or a placebo at 0, 15, 21, and 31 days were analyzed (Lyon study). Samples from a similarly designed trial on females (20 subjects) were collected in parallel (Lausanne study). Nuclear magnetic resonance (NMR)-based metabolomics was conducted to characterize metabolome changes induced by overfeeding and associated effects from polyphenol supplementation. The clinical trials are registered under the numbers NCT02145780 and NCT02225457 at ClinicalTrials.gov. Results Changes in plasma levels of many metabolic markers, including branched chain amino acids (BCAA), ketone bodies and glucose in both placebo as well as upon polyphenol intervention were identified in the Lyon study. Polyphenol supplementation counterbalanced levels of BCAA found to be induced by overfeeding. These results were further corroborated in the Lausanne female study. Conclusion Administration of grape polyphenol-rich extract over 1 month period was associated with a protective metabolic effect against overfeeding in adults.
Collapse
Affiliation(s)
- Simona Bartova
- Nestlé Research, EPFL Innovation Park, Lausanne, Switzerland
- *Correspondence: Simona Bartova,
| | - Francisco Madrid-Gambin
- Signal and Information Processing for Sensing Systems, Institute for Bioengineering of Catalonia (IBEC), Barcelona Institute of Science and Technology, Barcelona, Spain
| | - Luis Fernández
- Signal and Information Processing for Sensing Systems, Institute for Bioengineering of Catalonia (IBEC), Barcelona Institute of Science and Technology, Barcelona, Spain
- Department of Electronics and Biomedical Engineering, Universitat de Barcelona, Barcelona, Spain
| | - Jerome Carayol
- Nestlé Research, EPFL Innovation Park, Lausanne, Switzerland
| | - Emmanuelle Meugnier
- University of Lyon, CarMeN Laboratory and Centre de Recherche en Nutrition Humaine Rhône-Alpes (CRNH-RA), INSERM, INRAE, Claude Bernard University Lyon 1, Pierre-Bénite, France
| | - Bérénice Segrestin
- University of Lyon, CarMeN Laboratory and Centre de Recherche en Nutrition Humaine Rhône-Alpes (CRNH-RA), INSERM, INRAE, Claude Bernard University Lyon 1, Pierre-Bénite, France
| | - Pauline Delage
- University of Lyon, CarMeN Laboratory and Centre de Recherche en Nutrition Humaine Rhône-Alpes (CRNH-RA), INSERM, INRAE, Claude Bernard University Lyon 1, Pierre-Bénite, France
| | - Nathalie Vionnet
- Service d’Endocrinologie, Diabétologie et Métabolisme, CHU de Lausanne (CHUV), Lausanne, Switzerland
| | - Alexia Boizot
- Service d’Endocrinologie, Diabétologie et Métabolisme, CHU de Lausanne (CHUV), Lausanne, Switzerland
| | - Martine Laville
- University of Lyon, CarMeN Laboratory and Centre de Recherche en Nutrition Humaine Rhône-Alpes (CRNH-RA), INSERM, INRAE, Claude Bernard University Lyon 1, Pierre-Bénite, France
| | - Hubert Vidal
- University of Lyon, CarMeN Laboratory and Centre de Recherche en Nutrition Humaine Rhône-Alpes (CRNH-RA), INSERM, INRAE, Claude Bernard University Lyon 1, Pierre-Bénite, France
| | - Santiago Marco
- Signal and Information Processing for Sensing Systems, Institute for Bioengineering of Catalonia (IBEC), Barcelona Institute of Science and Technology, Barcelona, Spain
- Department of Electronics and Biomedical Engineering, Universitat de Barcelona, Barcelona, Spain
| | - Jörg Hager
- Nestlé Research, EPFL Innovation Park, Lausanne, Switzerland
| | - Sofia Moco
- Nestlé Research, EPFL Innovation Park, Lausanne, Switzerland
- Sofia Moco,
| |
Collapse
|
6
|
Paramasivam P, Meugnier E, Gokulakrishnan K, Ranjani H, Staimez LR, Weber MB, Narayan KMV, Vidal H, Tandon N, Prabhakaran D, Anjana RM, Mohan V, Rome S, Balasubramanyam M. Correction: Blood-derived miRNA levels are not correlated with metabolic or anthropometric parameters in obese pre-diabetic subjects but with systemic inflammation. PLoS One 2022; 17:e0272323. [PMID: 35881589 PMCID: PMC9321430 DOI: 10.1371/journal.pone.0272323] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
|
7
|
Segrestin B, Delage P, Nemeth A, Seyssel K, Disse E, Nazare JA, Lambert-Porcheron S, Meiller L, Sauvinet V, Chanon S, Simon C, Ratiney H, Beuf O, Pralong F, Yassin NAH, Boizot A, Gachet M, Burton-Pimentel KJ, Vidal H, Meugnier E, Vionnet N, Laville M. Polyphenol Supplementation Did Not Affect Insulin Sensitivity and Fat Deposition During One-Month Overfeeding in Randomized Placebo-Controlled Trials in Men and in Women. Front Nutr 2022; 9:854255. [PMID: 35614978 PMCID: PMC9125251 DOI: 10.3389/fnut.2022.854255] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2022] [Accepted: 04/05/2022] [Indexed: 12/30/2022] Open
Abstract
Two randomized placebo-controlled double-blind paralleled trials (42 men in Lyon, 19 women in Lausanne) were designed to test 2 g/day of a grape polyphenol extract during 31 days of high calorie-high fructose overfeeding. Hyperinsulinemic-euglycemic clamps and test meals with [1,1,1-13C3]-triolein were performed before and at the end of the intervention. Changes in body composition were assessed by dual-energy X-ray absorptiometry (DEXA). Fat volumes of the abdominal region and liver fat content were determined in men only, using 3D-magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) at 3T. Adipocyte's size was measured in subcutaneous fat biopsies. Bodyweight and fat mass increased during overfeeding, in men and in women. While whole body insulin sensitivity did not change, homeostasis model assessment of insulin resistance (HOMA-IR) and the hepatic insulin resistance index (HIR) increased during overfeeding. Liver fat increased in men. However, grape polyphenol supplementation did not modify the metabolic and anthropometric parameters or counteract the changes during overfeeding, neither in men nor in women. Polyphenol intake was associated with a reduction in adipocyte size in women femoral fat. Grape polyphenol supplementation did not counteract the moderated metabolic alterations induced by one month of high calorie-high fructose overfeeding in men and women. The clinical trials are registered under the numbers NCT02145780 and NCT02225457 at ClinicalTrials.gov and available at https://clinicaltrials.gov/ct2/show/NCT02145780 and https://clinicaltrials.gov/ct2/show/NCT02225457.
Collapse
Affiliation(s)
- Bérénice Segrestin
- INSERM, INRAe, CarMeN Laboratory, Claude Bernard Lyon 1 University, Lyon, France.,CRNH-RA, INSERM, INRAe, Hospices Civils de Lyon, Claude Bernard Lyon 1 University, Lyon, France.,Centre Hospitalier Lyon-Sud Service d'Endocrinologie Diabète Nutrition Lyon, Hospices Civils de Lyon, Lyon, France
| | - Pauline Delage
- INSERM, INRAe, CarMeN Laboratory, Claude Bernard Lyon 1 University, Lyon, France
| | - Angéline Nemeth
- CNRS, INSERM, CREATIS, Université de Lyon, INSA-Lyon, Claude Bernard Lyon 1 University, UJM-Saint Etienne, Lyon, France
| | - Kevin Seyssel
- INSERM, INRAe, CarMeN Laboratory, Claude Bernard Lyon 1 University, Lyon, France.,CRNH-RA, INSERM, INRAe, Hospices Civils de Lyon, Claude Bernard Lyon 1 University, Lyon, France
| | - Emmanuel Disse
- INSERM, INRAe, CarMeN Laboratory, Claude Bernard Lyon 1 University, Lyon, France.,CRNH-RA, INSERM, INRAe, Hospices Civils de Lyon, Claude Bernard Lyon 1 University, Lyon, France.,Centre Hospitalier Lyon-Sud Service d'Endocrinologie Diabète Nutrition Lyon, Hospices Civils de Lyon, Lyon, France
| | - Julie-Anne Nazare
- INSERM, INRAe, CarMeN Laboratory, Claude Bernard Lyon 1 University, Lyon, France.,CRNH-RA, INSERM, INRAe, Hospices Civils de Lyon, Claude Bernard Lyon 1 University, Lyon, France
| | | | - Laure Meiller
- CRNH-RA, INSERM, INRAe, Hospices Civils de Lyon, Claude Bernard Lyon 1 University, Lyon, France
| | - Valerie Sauvinet
- CRNH-RA, INSERM, INRAe, Hospices Civils de Lyon, Claude Bernard Lyon 1 University, Lyon, France
| | - Stéphanie Chanon
- INSERM, INRAe, CarMeN Laboratory, Claude Bernard Lyon 1 University, Lyon, France
| | - Chantal Simon
- INSERM, INRAe, CarMeN Laboratory, Claude Bernard Lyon 1 University, Lyon, France.,CRNH-RA, INSERM, INRAe, Hospices Civils de Lyon, Claude Bernard Lyon 1 University, Lyon, France
| | - Hélène Ratiney
- CNRS, INSERM, CREATIS, Université de Lyon, INSA-Lyon, Claude Bernard Lyon 1 University, UJM-Saint Etienne, Lyon, France
| | - Olivier Beuf
- CNRS, INSERM, CREATIS, Université de Lyon, INSA-Lyon, Claude Bernard Lyon 1 University, UJM-Saint Etienne, Lyon, France
| | - François Pralong
- Service of Endocrinology, Diabetes and Metabolism, Lausanne University Hospital, Lausanne, Switzerland
| | - Naba-Al-Huda Yassin
- Service of Endocrinology, Diabetes and Metabolism, Lausanne University Hospital, Lausanne, Switzerland
| | - Alexia Boizot
- Service of Endocrinology, Diabetes and Metabolism, Lausanne University Hospital, Lausanne, Switzerland
| | - Mélanie Gachet
- Service of Endocrinology, Diabetes and Metabolism, Lausanne University Hospital, Lausanne, Switzerland
| | - Kathryn J Burton-Pimentel
- Service of Endocrinology, Diabetes and Metabolism, Lausanne University Hospital, Lausanne, Switzerland
| | - Hubert Vidal
- INSERM, INRAe, CarMeN Laboratory, Claude Bernard Lyon 1 University, Lyon, France.,CRNH-RA, INSERM, INRAe, Hospices Civils de Lyon, Claude Bernard Lyon 1 University, Lyon, France
| | - Emmanuelle Meugnier
- INSERM, INRAe, CarMeN Laboratory, Claude Bernard Lyon 1 University, Lyon, France
| | - Nathalie Vionnet
- Service of Endocrinology, Diabetes and Metabolism, Lausanne University Hospital, Lausanne, Switzerland
| | - Martine Laville
- INSERM, INRAe, CarMeN Laboratory, Claude Bernard Lyon 1 University, Lyon, France.,CRNH-RA, INSERM, INRAe, Hospices Civils de Lyon, Claude Bernard Lyon 1 University, Lyon, France.,Centre Hospitalier Lyon-Sud Service d'Endocrinologie Diabète Nutrition Lyon, Hospices Civils de Lyon, Lyon, France
| |
Collapse
|
8
|
Delage P, Ségrestin B, Meugnier E, Chanon S, Durand A, Achaintre D, Scalbert A, Vidal H, Laville M. Étude de l’effet des polyphénols sur les mécanismes précoces de prise de poids chez des sujets sains soumis à un mois de surnutrition : focus sur le tissu adipeux. NUTR CLIN METAB 2022. [DOI: 10.1016/j.nupar.2021.12.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
9
|
Cussonneau L, Boyer C, Brun C, Deval C, Loizon E, Meugnier E, Gueret E, Dubois E, Taillandier D, Polge C, Béchet D, Gauquelin-Koch G, Evans AL, Arnemo JM, Swenson JE, Blanc S, Simon C, Lefai E, Bertile F, Combaret L. Concurrent BMP Signaling Maintenance and TGF-β Signaling Inhibition Is a Hallmark of Natural Resistance to Muscle Atrophy in the Hibernating Bear. Cells 2021; 10:cells10081873. [PMID: 34440643 PMCID: PMC8393865 DOI: 10.3390/cells10081873] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2021] [Revised: 07/14/2021] [Accepted: 07/20/2021] [Indexed: 12/17/2022] Open
Abstract
Muscle atrophy arises from a multiplicity of physio-pathological situations and has very detrimental consequences for the whole body. Although knowledge of muscle atrophy mechanisms keeps growing, there is still no proven treatment to date. This study aimed at identifying new drivers for muscle atrophy resistance. We selected an innovative approach that compares muscle transcriptome between an original model of natural resistance to muscle atrophy, the hibernating brown bear, and a classical model of induced atrophy, the unloaded mouse. Using RNA sequencing, we identified 4415 differentially expressed genes, including 1746 up- and 2369 down-regulated genes, in bear muscles between the active versus hibernating period. We focused on the Transforming Growth Factor (TGF)-β and the Bone Morphogenetic Protein (BMP) pathways, respectively, involved in muscle mass loss and maintenance. TGF-β- and BMP-related genes were overall down- and up-regulated in the non-atrophied muscles of the hibernating bear, respectively, and the opposite occurred for the atrophied muscles of the unloaded mouse. This was further substantiated at the protein level. Our data suggest TGF-β/BMP balance is crucial for muscle mass maintenance during long-term physical inactivity in the hibernating bear. Thus, concurrent activation of the BMP pathway may potentiate TGF-β inhibiting therapies already targeted to prevent muscle atrophy.
Collapse
Affiliation(s)
- Laura Cussonneau
- INRAE, Unité de Nutrition Humaine, Université Clermont Auvergne, UMR 1019, F-63000 Clermont-Ferrand, France; (C.B.); (C.D.); (D.T.); (C.P.); (D.B.); (E.L.)
- Correspondence: (L.C.); (L.C.); Tel.: +(33)4-7362-4824 (Lydie Combaret)
| | - Christian Boyer
- INRAE, Unité de Nutrition Humaine, Université Clermont Auvergne, UMR 1019, F-63000 Clermont-Ferrand, France; (C.B.); (C.D.); (D.T.); (C.P.); (D.B.); (E.L.)
| | - Charlotte Brun
- Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France; (C.B.); (S.B.); (F.B.)
| | - Christiane Deval
- INRAE, Unité de Nutrition Humaine, Université Clermont Auvergne, UMR 1019, F-63000 Clermont-Ferrand, France; (C.B.); (C.D.); (D.T.); (C.P.); (D.B.); (E.L.)
| | - Emmanuelle Loizon
- CarMen Laboratory, INSERM 1060, INRAE 1397, University of Lyon, F-69600 Oullins, France; (E.L.); (E.M.); (C.S.)
| | - Emmanuelle Meugnier
- CarMen Laboratory, INSERM 1060, INRAE 1397, University of Lyon, F-69600 Oullins, France; (E.L.); (E.M.); (C.S.)
| | - Elise Gueret
- Institut de Génomique Fonctionnelle (IGF), University Montpellier, CNRS, INSERM, 34094 Montpellier, France; (E.G.); (E.D.)
- Montpellier GenomiX, France Génomique, 34095 Montpellier, France
| | - Emeric Dubois
- Institut de Génomique Fonctionnelle (IGF), University Montpellier, CNRS, INSERM, 34094 Montpellier, France; (E.G.); (E.D.)
- Montpellier GenomiX, France Génomique, 34095 Montpellier, France
| | - Daniel Taillandier
- INRAE, Unité de Nutrition Humaine, Université Clermont Auvergne, UMR 1019, F-63000 Clermont-Ferrand, France; (C.B.); (C.D.); (D.T.); (C.P.); (D.B.); (E.L.)
| | - Cécile Polge
- INRAE, Unité de Nutrition Humaine, Université Clermont Auvergne, UMR 1019, F-63000 Clermont-Ferrand, France; (C.B.); (C.D.); (D.T.); (C.P.); (D.B.); (E.L.)
| | - Daniel Béchet
- INRAE, Unité de Nutrition Humaine, Université Clermont Auvergne, UMR 1019, F-63000 Clermont-Ferrand, France; (C.B.); (C.D.); (D.T.); (C.P.); (D.B.); (E.L.)
| | | | - Alina L. Evans
- Department of Forestry and Wildlife Management, Inland Norway University of Applied Sciences, Campus Evenstad, NO-2480 Koppang, Norway; (A.L.E.); (J.M.A.)
| | - Jon M. Arnemo
- Department of Forestry and Wildlife Management, Inland Norway University of Applied Sciences, Campus Evenstad, NO-2480 Koppang, Norway; (A.L.E.); (J.M.A.)
- Department of Wildlife, Fish, and Environmental Studies, Swedish University of Agricultural Sciences, SE-901 83 Umeå, Sweden
| | - Jon E. Swenson
- Faculty of Environmental Sciences and Natural Resource Management, Norwegian University of Life Sciences, NO-1432 Ås, Norway;
| | - Stéphane Blanc
- Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France; (C.B.); (S.B.); (F.B.)
| | - Chantal Simon
- CarMen Laboratory, INSERM 1060, INRAE 1397, University of Lyon, F-69600 Oullins, France; (E.L.); (E.M.); (C.S.)
| | - Etienne Lefai
- INRAE, Unité de Nutrition Humaine, Université Clermont Auvergne, UMR 1019, F-63000 Clermont-Ferrand, France; (C.B.); (C.D.); (D.T.); (C.P.); (D.B.); (E.L.)
| | - Fabrice Bertile
- Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France; (C.B.); (S.B.); (F.B.)
| | - Lydie Combaret
- INRAE, Unité de Nutrition Humaine, Université Clermont Auvergne, UMR 1019, F-63000 Clermont-Ferrand, France; (C.B.); (C.D.); (D.T.); (C.P.); (D.B.); (E.L.)
- Correspondence: (L.C.); (L.C.); Tel.: +(33)4-7362-4824 (Lydie Combaret)
| |
Collapse
|
10
|
Robert C, Penhoat A, Guillot N, Meugnier E, Chanon S, Loizon E, Caillet F, Monnoye M, Vidal H, Gérard P, Vaysse C, Michalski MC. Rapeseed and Soy Lecithin As Food Additives Vectors of α-Linolenic Acid: Impacts on High-Fat Induced Adiposity, Inflammation and Gut Microbiota in Mice. Curr Dev Nutr 2021. [DOI: 10.1093/cdn/nzab037_074] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Objectives
Dietary synthetic emulsifiers have recently been shown to promote metabolic syndrome and alter gut microbiota. The effects of natural emulsifiers, such as vegetable lecithin, remain, however, poorly described. Our objective was to evaluate, in mice, the impact of soy and rapeseed lecithin, both rich in essential α-linolenic acid (ALA), when incorporated in high-fat (HF) Western diets on the bioavailability of ALA, as well as on HF-induced adiposity, inflammation and gut microbiota.
Methods
For 13 weeks, male Swiss mice (n = 72) were fed either a standard Chow diet, a control semi-synthetic HF-diet (25 wt% lipids) poor in ALA (HFC), or different ALA-enriched (4.7% of total fatty acids) HF-diets containing 0% lecithin (HFA-L0), a nutritional dose of soy or rapeseed lecithin (10 wt% of lipids; HFA-SL10, HFA-RL10), or a 20 wt% supplemental dose of RL (HFA-RL20). Histomorphology of the epididymal adipose tissue (EAT) was analysed; hepatic lipid composition was determined by GC-FID, gene expression by RT-PCR, and faecal microbiota composition by 16S sequencing.
Results
Within ALA-rich HF diets, the hepatic bioavailability of ALA was similar whether ALA was vectorised as lecithin (HFA-RL10, HFA-RL20, HFA-SL10) or as oil only (HFA-L0) (yet, all higher than HFC). Similarly to HFC, HFA-SL10 and HFA-RL20, but not HFA-RL10, increased body weight gain (P < 0.001), visceral adiposity (P < 0.001) and adipocyte hypertrophy (P < 0.05), compared to Chow. The addition of lecithin in HF-diets, regardless of origin or dose, cancelled the anti-inflammatory effect of ALA observed in HFA-L0 on the expression of genes involved in macrophage infiltration in the EAT (e.g., Tnfα, Cd11c). Only HFA-RL10 increased gut microbiota α-diversity compared to HFC (P < 0.05), and altered the abundance of several gut bacterial groups, such as Lachnospiraceae and Desulfovibrionaceae.
Conclusions
Although the incorporation of neither soy nor rapeseed lecithin in HF-diets improved ALA hepatic bioavailability, the two lecithins exerted differential metabolic effects in mice. At a nutritional dose, rapeseed lecithin, unlike soy lecithin, did not significantly enhance visceral adiposity comparatively to a Chow diet, and increased gut bacterial diversity. Rapeseed lecithin may therefore be considered as a promising food ingredient.
Funding Sources
ANRT CIFRE PhD grant (UMT ACTIA BALI).
Collapse
|
11
|
Le Barz M, Vors C, Combe E, Joumard-Cubizolles L, Lecomte M, Joffre F, Trauchessec M, Pesenti S, Loizon E, Breyton AE, Meugnier E, Bertrand K, Drai J, Robert C, Durand A, Cuerq C, Gaborit P, Leconte N, Bernalier-Donadille A, Cotte E, Laville M, Lambert-Porcheron S, Ouchchane L, Vidal H, Malpuech-Brugère C, Cheillan D, Michalski MC. Milk polar lipids favorably alter circulating and intestinal ceramide and sphingomyelin species in postmenopausal women. JCI Insight 2021; 6:146161. [PMID: 33857018 PMCID: PMC8262315 DOI: 10.1172/jci.insight.146161] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2020] [Accepted: 04/09/2021] [Indexed: 01/16/2023] Open
Abstract
BACKGROUND High circulating levels of ceramides (Cer) and sphingomyelins (SM) are associated with cardiometabolic diseases. The consumption of whole fat dairy products, naturally containing such polar lipids (PL), is associated with health benefits, but the impact on sphingolipidome remains unknown. METHODS In a 4-week randomized controlled trial, 58 postmenopausal women daily consumed milk PL-enriched cream cheese (0, 3, or 5 g of milk PL). Postprandial metabolic explorations were performed before and after supplementation. Analyses included SM and Cer species in serum, chylomicrons, and feces. The ileal contents of 4 ileostomy patients were also explored after acute milk PL intake. RESULTS Milk PL decreased serum atherogenic C24:1 Cer, C16:1 SM, and C18:1 SM species (Pgroup < 0.05). Changes in serum C16+18 SM species were positively correlated with the reduction of cholesterol (r = 0.706), LDL-C (r = 0.666), and ApoB (r = 0.705) (P < 0.001). Milk PL decreased chylomicron content in total SM and C24:1 Cer (Pgroup < 0.001), parallel to a marked increase in total Cer in feces (Pgroup < 0.001). Milk PL modulated some specific SM and Cer species in both ileal efflux and feces, suggesting differential absorption and metabolization processes in the gut. CONCLUSION Milk PL supplementation decreased atherogenic SM and Cer species associated with the improvement of cardiovascular risk markers. Our findings bring insights on sphingolipid metabolism in the gut, especially Cer, as signaling molecules potentially participating in the beneficial effects of milk PL. TRIAL REGISTRATION ClinicalTrials.gov, NCT02099032, NCT02146339. FUNDING ANR-11-ALID-007-01; PHRCI-2014: VALOBAB, no. 14-007; CNIEL; GLN 2018-11-07; HCL (sponsor).
Collapse
Affiliation(s)
- Mélanie Le Barz
- Univ Lyon, CarMeN laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, Charles Mérieux Medical School, 69310, Pierre-Bénite, France
| | - Cécile Vors
- Univ Lyon, CarMeN laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, Charles Mérieux Medical School, 69310, Pierre-Bénite, France.,TCentre de Recherche en Nutrition Humaine Rhône-Alpes, Univ-Lyon, CarMeN Laboratory, Université Claude Bernard Lyon1, Hospices Civils de Lyon, CENS, FCRIN/FORCE Network, 69310, Pierre-Bénite, France
| | - Emmanuel Combe
- Univ Lyon, CarMeN laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, Charles Mérieux Medical School, 69310, Pierre-Bénite, France
| | - Laurie Joumard-Cubizolles
- Université Clermont Auvergne, INRAE, UNH, Unité de Nutrition Humaine, CRNH Auvergne, 63000, Clermont-Ferrand, France
| | - Manon Lecomte
- Univ Lyon, CarMeN laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, Charles Mérieux Medical School, 69310, Pierre-Bénite, France.,TCentre de Recherche en Nutrition Humaine Rhône-Alpes, Univ-Lyon, CarMeN Laboratory, Université Claude Bernard Lyon1, Hospices Civils de Lyon, CENS, FCRIN/FORCE Network, 69310, Pierre-Bénite, France
| | - Florent Joffre
- ITERG, ZA Pessac-Canéjan, 11 Rue Gaspard Monge, 33610, Canéjan, France
| | - Michèle Trauchessec
- Hospices Civils de Lyon, 69000, Lyon, France.,Unité Maladies Héréditaires du Métabolisme, Service de Biochimie et Biologie Moléculaire Grand Est, Centre de Biologie et de Pathologie Est, Hospices Civils de Lyon, 69677, Bron, France
| | - Sandra Pesenti
- Univ Lyon, CarMeN laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, Charles Mérieux Medical School, 69310, Pierre-Bénite, France
| | - Emmanuelle Loizon
- Univ Lyon, CarMeN laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, Charles Mérieux Medical School, 69310, Pierre-Bénite, France
| | - Anne-Esther Breyton
- Univ Lyon, CarMeN laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, Charles Mérieux Medical School, 69310, Pierre-Bénite, France.,TCentre de Recherche en Nutrition Humaine Rhône-Alpes, Univ-Lyon, CarMeN Laboratory, Université Claude Bernard Lyon1, Hospices Civils de Lyon, CENS, FCRIN/FORCE Network, 69310, Pierre-Bénite, France
| | - Emmanuelle Meugnier
- Univ Lyon, CarMeN laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, Charles Mérieux Medical School, 69310, Pierre-Bénite, France
| | - Karène Bertrand
- ITERG, ZA Pessac-Canéjan, 11 Rue Gaspard Monge, 33610, Canéjan, France
| | - Jocelyne Drai
- Univ Lyon, CarMeN laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, Charles Mérieux Medical School, 69310, Pierre-Bénite, France.,Hospices Civils de Lyon, 69000, Lyon, France.,Unité de Nutrition Endocrinologie Métabolisme, Service de Biochimie, Centre de Biologie et de Pathologie Sud, Hospices Civils de Lyon, 69495, Pierre-Bénite, France
| | - Chloé Robert
- Univ Lyon, CarMeN laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, Charles Mérieux Medical School, 69310, Pierre-Bénite, France.,TCentre de Recherche en Nutrition Humaine Rhône-Alpes, Univ-Lyon, CarMeN Laboratory, Université Claude Bernard Lyon1, Hospices Civils de Lyon, CENS, FCRIN/FORCE Network, 69310, Pierre-Bénite, France
| | - Annie Durand
- Univ Lyon, CarMeN laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, Charles Mérieux Medical School, 69310, Pierre-Bénite, France
| | - Charlotte Cuerq
- Univ Lyon, CarMeN laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, Charles Mérieux Medical School, 69310, Pierre-Bénite, France.,Hospices Civils de Lyon, 69000, Lyon, France.,Unité de Nutrition Endocrinologie Métabolisme, Service de Biochimie, Centre de Biologie et de Pathologie Sud, Hospices Civils de Lyon, 69495, Pierre-Bénite, France
| | - Patrice Gaborit
- ACTALIA Dairy Products and Technologies, Avenue François Mitterrand, BP49, 17700, Surgères, France.,ENILIA ENSMIC, Avenue François Mitterrand, 17700, Surgères, France
| | - Nadine Leconte
- INRAE, Institut Agro, STLO (Science et Technologie du Lait et de l'Œuf), 35042, Rennes, France
| | | | - Eddy Cotte
- Hospices Civils de Lyon, 69000, Lyon, France.,Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Service de chirurgie digestive, 69310, Pierre-Bénite, France.,Université Claude Bernard Lyon 1, Faculté de médecine Lyon-Sud-Charles Mérieux, EMR 3738, 69600, Oullins, France
| | - Martine Laville
- Univ Lyon, CarMeN laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, Charles Mérieux Medical School, 69310, Pierre-Bénite, France.,TCentre de Recherche en Nutrition Humaine Rhône-Alpes, Univ-Lyon, CarMeN Laboratory, Université Claude Bernard Lyon1, Hospices Civils de Lyon, CENS, FCRIN/FORCE Network, 69310, Pierre-Bénite, France.,Hospices Civils de Lyon, 69000, Lyon, France.,Université Claude Bernard Lyon 1, Faculté de médecine Lyon-Sud-Charles Mérieux, EMR 3738, 69600, Oullins, France
| | - Stéphanie Lambert-Porcheron
- TCentre de Recherche en Nutrition Humaine Rhône-Alpes, Univ-Lyon, CarMeN Laboratory, Université Claude Bernard Lyon1, Hospices Civils de Lyon, CENS, FCRIN/FORCE Network, 69310, Pierre-Bénite, France.,Hospices Civils de Lyon, 69000, Lyon, France
| | - Lemlih Ouchchane
- Université Clermont Auvergne, CNRS, SIGMA Clermont, Institut Pascal, 63000, Clermont-Ferrand, France.,CHU Clermont-Ferrand, Unité de Biostatistique-Informatique Médicale, 63000, Clermont-Ferrand, France
| | - Hubert Vidal
- Univ Lyon, CarMeN laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, Charles Mérieux Medical School, 69310, Pierre-Bénite, France
| | - Corinne Malpuech-Brugère
- Université Clermont Auvergne, INRAE, UNH, Unité de Nutrition Humaine, CRNH Auvergne, 63000, Clermont-Ferrand, France
| | - David Cheillan
- Univ Lyon, CarMeN laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, Charles Mérieux Medical School, 69310, Pierre-Bénite, France.,Hospices Civils de Lyon, 69000, Lyon, France.,Unité Maladies Héréditaires du Métabolisme, Service de Biochimie et Biologie Moléculaire Grand Est, Centre de Biologie et de Pathologie Est, Hospices Civils de Lyon, 69677, Bron, France
| | - Marie-Caroline Michalski
- Univ Lyon, CarMeN laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, Charles Mérieux Medical School, 69310, Pierre-Bénite, France.,TCentre de Recherche en Nutrition Humaine Rhône-Alpes, Univ-Lyon, CarMeN Laboratory, Université Claude Bernard Lyon1, Hospices Civils de Lyon, CENS, FCRIN/FORCE Network, 69310, Pierre-Bénite, France
| |
Collapse
|
12
|
Guimarães KSDL, Braga VDA, Noronha SISRD, Costa WKAD, Makki K, Cruz JDC, Brandão LR, Chianca Junior DA, Meugnier E, Leulier F, Vidal H, Magnani M, de Brito Alves JL. Lactiplantibacillus plantarum WJL administration during pregnancy and lactation improves lipid profile, insulin sensitivity and gut microbiota diversity in dyslipidemic dams and protects male offspring against cardiovascular dysfunction in later life. Food Funct 2021; 11:8939-8950. [PMID: 33000822 DOI: 10.1039/d0fo01718c] [Citation(s) in RCA: 21] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
BACKGROUND AND AIM Maternal dyslipidemia is recognized as a risk factor for the development of arterial hypertension (AH) and cardiovascular dysfunction in offspring. Here we evaluated the effects of probiotic administration of a specific strain of Lactiplantibacillus plantarum (WJL) during pregnancy and lactation on gut microbiota and metabolic profile in dams fed with a high-fat and high-cholesterol (HFHC) diet and its long-term effects on the cardiovascular function in male rat offspring. METHODS AND RESULTS Pregnant Wistar rats were allocated into three groups: dams fed a control diet (CTL = 5), dams fed a HFHC diet (DLP = 5) and dams fed a HFHC diet and receiving L. plantarum WJL during pregnancy and lactation (DLP-LpWJL). L. plantarum WJL (1 × 109 CFU) or vehicle (NaCl, 0.9%) was administered daily by oral gavage for 6 weeks, covering the pregnancy and lactation periods. After weaning, male offspring received a standard diet up to 90 days of life. Biochemical measurements and gut microbiota were evaluated in dams. In male offspring, blood pressure (BP), heart rate (HR) and vascular reactivity were evaluated at 90 days of age. Dams fed with a HFHC diet during pregnancy and lactation had increased lipid profile and insulin resistance and showed dysbiotic gut microbiota. Administration of L. plantarum WJL to dams having maternal dyslipidemia improved gut microbiota composition, lipid profile and insulin resistance in them. Blood pressure was augmented and vascular reactivity was impaired with a higher contractile response and a lower response to endothelium-dependent vasorelaxation in DLP male offspring. In contrast, male offspring of DLP-LpWJL dams had reduced blood pressure and recovered vascular function in later life. CONCLUSION Administration of L. plantarum WJL during pregnancy and lactation in dams improved gut microbiota diversity, reduced maternal dyslipidemia and prevented cardiovascular dysfunction in male rat offspring.
Collapse
Affiliation(s)
| | - Valdir de Andrade Braga
- Department of Biotechnology, Biotechnology Center, Federal University of Paraíba, João Pessoa, PB, Brazil
| | - Sylvana I S Rendeiro de Noronha
- Department of Biological Science, Laboratory of Cardiovascular Physiology, Federal University of Ouro Preto, Ouro Preto, MG, Brazil
| | | | - Kassem Makki
- Department of Molecular and Clinical Medicine/Wallenberg Laboratory, Institute of Medicine, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden
| | - Josiane de Campos Cruz
- Department of Biotechnology, Biotechnology Center, Federal University of Paraíba, João Pessoa, PB, Brazil
| | - Larissa Ramalho Brandão
- Department of Nutrition, Health Sciences Center, Federal University of Paraiba, Joao Pessoa, Brazil.
| | - Deoclecio Alves Chianca Junior
- Department of Biological Science, Laboratory of Cardiovascular Physiology, Federal University of Ouro Preto, Ouro Preto, MG, Brazil
| | - Emmanuelle Meugnier
- Univ-Lyon, CarMeN (Cardio, Metabolism, Diabetes and Nutrition) Laboratory, INSERM, INRAE, Université Claude Bernard Lyon 1, INSA Lyon, Oullins, France
| | - François Leulier
- Univ-Lyon, Institut de Génomique Fonctionnelle de Lyon (IGFL), Ecole Normale Supérieure de Lyon, Centre National de la Recherche Scientifique, Université Claude Bernard Lyon 1, Lyon, France
| | - Hubert Vidal
- Univ-Lyon, CarMeN (Cardio, Metabolism, Diabetes and Nutrition) Laboratory, INSERM, INRAE, Université Claude Bernard Lyon 1, INSA Lyon, Oullins, France
| | - Marciane Magnani
- Department of Food Engineering, Technology Center, Federal University of Paraiba, Joao Pessoa, Brazil
| | - José Luiz de Brito Alves
- Department of Nutrition, Health Sciences Center, Federal University of Paraiba, Joao Pessoa, Brazil.
| |
Collapse
|
13
|
Robert C, Buisson C, Laugerette F, Abrous H, Rainteau D, Humbert L, Vande Weghe J, Meugnier E, Loizon E, Caillet F, Van Dorsselaer B, Urdaci M, Vaysse C, Michalski MC. Impact of Rapeseed and Soy Lecithin on Postprandial Lipid Metabolism, Bile Acid Profile, and Gut Bacteria in Mice. Mol Nutr Food Res 2021; 65:e2001068. [PMID: 33742729 DOI: 10.1002/mnfr.202001068] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2020] [Revised: 02/16/2021] [Indexed: 01/01/2023]
Abstract
SCOPE Synthetic emulsifiers have recently been shown to promote metabolic syndrome and considerably alter gut microbiota. Yet, data are lacking regarding the effects of natural emulsifiers, such as plant lecithins rich in essential α-linolenic acid (ALA), on gut and metabolic health. METHODS AND RESULTS For 5 days, male Swiss mice are fed diets containing similar amounts of ALA and 0, 1, 3, or 10% rapeseed lecithin (RL) or 10% soy lecithin (SL). Following an overnight fast, they are force-fed the same oil mixture and euthanized after 90 minutes. The consumption of lecithin significantly increased fecal levels of the Clostridium leptum group (p = 0.0004), regardless of origin or dose, without altering hepatic or intestinal expression of genes of lipid metabolism. 10%-RL increased ALA abundance in plasma triacylglycerols at 90 minutes, reduced cecal bile acid hydrophobicity, and increased their sulfatation, as demonstrated by the increased hepatic RNA expression of Sult2a1 (p = 0.037) and cecal cholic acid-7 sulfate (CA-7S) concentration (p = 0.05) versus 0%-lecithin. CONCLUSION After only 5 days, nutritional doses of RL and SL modified gut bacteria in mice, by specifically increasing C. leptum group. RL also increased postprandial ALA abundance and induced beneficial modifications of the bile acid profile. ALA-rich lecithins, especially RL, may then appear as promising natural emulsifiers.
Collapse
Affiliation(s)
- Chloé Robert
- CarMeN laboratory, INRAE, UMR1397, INSERM, U1060, INSA-Lyon, Université Claude Bernard Lyon 1, Pierre-Bénite, FR-69310, France
- ITERG, Equipe Nutrition, Santé et Biochimie des Lipides, Canéjan, FR-33610, France
| | - Charline Buisson
- CarMeN laboratory, INRAE, UMR1397, INSERM, U1060, INSA-Lyon, Université Claude Bernard Lyon 1, Pierre-Bénite, FR-69310, France
| | - Fabienne Laugerette
- CarMeN laboratory, INRAE, UMR1397, INSERM, U1060, INSA-Lyon, Université Claude Bernard Lyon 1, Pierre-Bénite, FR-69310, France
| | - Hélène Abrous
- ITERG, Equipe Nutrition, Santé et Biochimie des Lipides, Canéjan, FR-33610, France
| | - Dominique Rainteau
- Sorbonne Universités, UPMC Univ. Paris 6, ENS, PSL Research University, CNRS, INSERM, APHP, Laboratory of BioMolecules (LBM), Paris, FR-75005, France
| | - Lydie Humbert
- Sorbonne Universités, UPMC Univ. Paris 6, ENS, PSL Research University, CNRS, INSERM, APHP, Laboratory of BioMolecules (LBM), Paris, FR-75005, France
| | - Justine Vande Weghe
- UMR5248, Laboratory of Microbiology and Applied Biochemistry, Bordeaux Sciences Agro, Gradignan, FR-33170, France
| | - Emmanuelle Meugnier
- CarMeN laboratory, INRAE, UMR1397, INSERM, U1060, INSA-Lyon, Université Claude Bernard Lyon 1, Pierre-Bénite, FR-69310, France
| | - Emmanuelle Loizon
- CarMeN laboratory, INRAE, UMR1397, INSERM, U1060, INSA-Lyon, Université Claude Bernard Lyon 1, Pierre-Bénite, FR-69310, France
| | - François Caillet
- CarMeN laboratory, INRAE, UMR1397, INSERM, U1060, INSA-Lyon, Université Claude Bernard Lyon 1, Pierre-Bénite, FR-69310, France
| | - Benjamin Van Dorsselaer
- CarMeN laboratory, INRAE, UMR1397, INSERM, U1060, INSA-Lyon, Université Claude Bernard Lyon 1, Pierre-Bénite, FR-69310, France
| | - Maria Urdaci
- UMR5248, Laboratory of Microbiology and Applied Biochemistry, Bordeaux Sciences Agro, Gradignan, FR-33170, France
| | - Carole Vaysse
- ITERG, Equipe Nutrition, Santé et Biochimie des Lipides, Canéjan, FR-33610, France
| | - Marie-Caroline Michalski
- CarMeN laboratory, INRAE, UMR1397, INSERM, U1060, INSA-Lyon, Université Claude Bernard Lyon 1, Pierre-Bénite, FR-69310, France
| |
Collapse
|
14
|
Robert C, Couëdelo L, Knibbe C, Fonseca L, Buisson C, Errazuriz-Cerda E, Meugnier E, Loizon E, Vaysse C, Michalski MC. Rapeseed Lecithin Increases Lymphatic Lipid Output and α-Linolenic Acid Bioavailability in Rats. J Nutr 2020; 150:2900-2911. [PMID: 32937654 DOI: 10.1093/jn/nxaa244] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2020] [Revised: 05/07/2020] [Accepted: 07/21/2020] [Indexed: 12/26/2022] Open
Abstract
BACKGROUND Soybean lecithin, a plant-based emulsifier widely used in food, is capable of modulating postprandial lipid metabolism. With arising concerns of sustainability, alternative sources of vegetal lecithin are urgently needed, and their metabolic effects must be characterized. OBJECTIVES We evaluated the impact of increasing doses of rapeseed lecithin (RL), rich in essential α-linolenic acid (ALA), on postprandial lipid metabolism and ALA bioavailability in lymph-cannulated rats. METHODS Male Wistar rats (8 weeks old) undergoing a mesenteric lymph duct cannulation were intragastrically administered 1 g of an oil mixture containing 4% ALA and 0, 1, 3, 10, or 30% RL (5 groups). Lymph fractions were collected for 6 h. Lymph lipids and chylomicrons (CMs) were characterized. The expression of genes implicated in intestinal lipid metabolism was determined in the duodenum at 6 h. Data was analyzed using either sigmoidal or linear mixed-effects models, or one-way ANOVA, where appropriate. RESULTS RL dose-dependently increased the lymphatic recovery (AUC) of total lipids (1100 μg/mL·h per additional RL%; P = 0.010) and ALA (50 μg/mL·h per additional RL%; P = 0.0076). RL induced a faster appearance of ALA in lymph, as evidenced by the exponential decrease of the rate of appearance of ALA with RL (R2 = 0.26; P = 0.0064). Although the number of CMs was unaffected by RL, CM diameter was increased in the 30%-RL group, compared to the control group (0% RL), by 86% at 3-4 h (P = 0.065) and by 81% at 4-6 h (P = 0.0002) following administration. This increase was positively correlated with the duodenal mRNA expression of microsomal triglyceride transfer protein (Mttp; ρ= 0.63; P = 0.0052). The expression of Mttp and secretion-associated, ras-related GTPase 1 gene homolog B (Sar1b, CM secretion), carnitine palmitoyltransferase IA (Cpt1a) and acyl-coenzyme A oxidase 1 (Acox1, beta-oxidation), and fatty acid desaturase 2 (Fads2, bioconversion of ALA into long-chain n-3 PUFAs) were, respectively, 49%, 29%, 74%, 48%, and 55% higher in the 30%-RL group vs. the control group (P < 0.05). CONCLUSIONS In rats, RL enhanced lymphatic lipid output, as well as the rate of appearance of ALA, which may promote its subsequent bioavailability and metabolic fate.
Collapse
Affiliation(s)
- Chloé Robert
- Univ-Lyon, CarMeN (Cardiovascular, Metabolism, Diabetes, Nutrition) Laboratory, National Institute for Agricultural and Environmental Research (INRAE) UMR1397, National Institute of Health and Medical Research (INSERM) U1060, National Institute of Applied Science of Lyon (INSA-Lyon), Université Claude Bernard Lyon 1, Pierre-Bénite, France.,ITERG, Equipe Nutrition, Santé et Biochimie des Lipides, Canéjan, France
| | - Leslie Couëdelo
- ITERG, Equipe Nutrition, Santé et Biochimie des Lipides, Canéjan, France
| | - Carole Knibbe
- Univ-Lyon, CarMeN (Cardiovascular, Metabolism, Diabetes, Nutrition) Laboratory, National Institute for Agricultural and Environmental Research (INRAE) UMR1397, National Institute of Health and Medical Research (INSERM) U1060, National Institute of Applied Science of Lyon (INSA-Lyon), Université Claude Bernard Lyon 1, Pierre-Bénite, France.,Inria "Beagle" team, Antenne Lyon la Doua, Villeurbanne, France
| | - Laurence Fonseca
- ITERG, Equipe Nutrition, Santé et Biochimie des Lipides, Canéjan, France
| | - Charline Buisson
- Univ-Lyon, CarMeN (Cardiovascular, Metabolism, Diabetes, Nutrition) Laboratory, National Institute for Agricultural and Environmental Research (INRAE) UMR1397, National Institute of Health and Medical Research (INSERM) U1060, National Institute of Applied Science of Lyon (INSA-Lyon), Université Claude Bernard Lyon 1, Pierre-Bénite, France
| | | | - Emmanuelle Meugnier
- Univ-Lyon, CarMeN (Cardiovascular, Metabolism, Diabetes, Nutrition) Laboratory, National Institute for Agricultural and Environmental Research (INRAE) UMR1397, National Institute of Health and Medical Research (INSERM) U1060, National Institute of Applied Science of Lyon (INSA-Lyon), Université Claude Bernard Lyon 1, Pierre-Bénite, France
| | - Emmanuelle Loizon
- Univ-Lyon, CarMeN (Cardiovascular, Metabolism, Diabetes, Nutrition) Laboratory, National Institute for Agricultural and Environmental Research (INRAE) UMR1397, National Institute of Health and Medical Research (INSERM) U1060, National Institute of Applied Science of Lyon (INSA-Lyon), Université Claude Bernard Lyon 1, Pierre-Bénite, France
| | - Carole Vaysse
- ITERG, Equipe Nutrition, Santé et Biochimie des Lipides, Canéjan, France
| | - Marie-Caroline Michalski
- Univ-Lyon, CarMeN (Cardiovascular, Metabolism, Diabetes, Nutrition) Laboratory, National Institute for Agricultural and Environmental Research (INRAE) UMR1397, National Institute of Health and Medical Research (INSERM) U1060, National Institute of Applied Science of Lyon (INSA-Lyon), Université Claude Bernard Lyon 1, Pierre-Bénite, France
| |
Collapse
|
15
|
Vincent M, Ménard O, Etienne J, Ossemond J, Durand A, Buffin R, Loizon E, Meugnier E, Deglaire A, Dupont D, Picaud JC, Knibbe C, Michalski MC, Penhoat A. Human milk pasteurisation reduces pre-lipolysis but not digestive lipolysis and moderately decreases intestinal lipid uptake in a combination of preterm infant in vitro models. Food Chem 2020; 329:126927. [PMID: 32516717 DOI: 10.1016/j.foodchem.2020.126927] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2020] [Revised: 04/24/2020] [Accepted: 04/26/2020] [Indexed: 11/19/2022]
Abstract
Donor human milk, pasteurised for safety reasons, is the first alternative for feeding preterm infants when mothers' own milk is unavailable. Breastmilk pasteurisation impact on lipid digestion and absorption was evaluated by a static in vitro digestion model for preterm infants coupled with intestinal absorption using Caco-2/TC7 cells. Lipid absorption was quantified by digital image analysis of lipid droplets, by measurement of basolateral triglyceride concentration and by analysing the expression of major genes involved. After in vitro digestion, lipolysis extent was 13% lower in pasteurised human milk (PHM) than in raw human milk (RHM). In Caco-2/TC7 cells, the number of lipid droplets was identical for both milk types, while the mean droplet area was 17% smaller with PHM. Altogether, pasteurisation decreased the pre-lipolysis of human milk. This initial difference in free fatty acid amount was only partially buffered by the subsequent processes of in vitro digestion and cellular lipid absorption.
Collapse
Affiliation(s)
- Marine Vincent
- Univ Lyon, CarMeN Laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon1, Pierre-Bénite, France; Neonatology Department, Croix-Rousse Hospital, Hospices Civils de Lyon, Lyon, France.
| | | | - Julie Etienne
- Univ Lyon, CarMeN Laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon1, Pierre-Bénite, France; Project-Team BEAGLE, INRIA, Villeurbanne, France.
| | | | - Annie Durand
- Univ Lyon, CarMeN Laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon1, Villeurbanne, France.
| | - Rachel Buffin
- Neonatology Department, Croix-Rousse Hospital, Hospices Civils de Lyon, Lyon, France.
| | - Emmanuelle Loizon
- Univ Lyon, CarMeN Laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon1, Pierre-Bénite, France.
| | - Emmanuelle Meugnier
- Univ Lyon, CarMeN Laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon1, Pierre-Bénite, France.
| | | | | | - Jean-Charles Picaud
- Neonatology Department, Croix-Rousse Hospital, Hospices Civils de Lyon, Lyon, France; Univ Lyon, CarMeN Laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon1, Pierre-Bénite, France.
| | - Carole Knibbe
- Univ Lyon, CarMeN Laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon1, Pierre-Bénite, France; Project-Team BEAGLE, INRIA, Villeurbanne, France.
| | - Marie-Caroline Michalski
- Univ Lyon, CarMeN Laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon1, Pierre-Bénite, France.
| | - Armelle Penhoat
- Univ Lyon, CarMeN Laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon1, Pierre-Bénite, France.
| |
Collapse
|
16
|
Berger E, Colosetti P, Jalabert A, Meugnier E, Wiklander OP, Jouhet J, Errazurig-Cerda E, Chanon S, Gupta D, Rautureau GJ, Geloen A, El-Andaloussi S, Panthu B, Rieusset J, Rome S. Use of Nanovesicles from Orange Juice to Reverse Diet-Induced Gut Modifications in Diet-Induced Obese Mice. Mol Ther Methods Clin Dev 2020; 18:880-892. [PMID: 32953937 PMCID: PMC7481887 DOI: 10.1016/j.omtm.2020.08.009] [Citation(s) in RCA: 48] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2020] [Accepted: 08/10/2020] [Indexed: 02/06/2023]
Abstract
We have determined whether orange juice-derived nanovesicles (ONVs) could be used for the treatment of obesity-associated intestinal complications. ONVs were characterized by lipidomic, metabolomic, electron microscopy. In vitro, intestinal barriers (IBs = Caco-2+HT-29-MTX) were treated with ONVs and co-cultured with adipocytes to monitor IB fat release. In vivo, obesity was induced with a high-fat, high-sucrose diet (HFHSD mice) for 12 weeks. Then, half of HFHSD mice were gavaged with ONVs. One-month ONV treatment did not modify HFHSD-induced insulin resistance but reversed diet-induced gut modifications. In the jejunum, ONVs increased villi size, reduced triglyceride content, and modulated mRNA levels of genes involved in immune response (tumor necrosis factor [TNF]-α and interleukin [IL]-1β), barrier permeability (CLDN1, OCLN, ZO1), fat absorption, and chylomicron release. ONVs targeted microsomal triglyceride transfer protein (MTP) and angiopoietin-like protein-4 (ANGPTL4), two therapeutic targets to reduce plasma lipids and inflammation in gastrointestinal diseases. Interestingly, ONV treatment did not aggravate liver steatosis, as MTP mRNA was increased in the liver. Therefore, ONVs protected both intestine and the liver from fat overload associated with the HFHSD. As ONVs concentrated amino acids and bioactive lipids versus orange juice, which are deficient in obese patients, the use of ONVs as a dietary supplement could bring physiological relevant compounds in the jejunum to accelerate the restoration of intestinal functions during weight loss in obese patients.
Collapse
Affiliation(s)
- Emmanuelle Berger
- CarMeN Laboratory (INRAe U1397, INSERM U1060, Lyon 1 University, INSA Lyon), Bâtiment CENS ELI-2D, Pierre-Bénite, France
| | - Pascal Colosetti
- CarMeN Laboratory (INRAe U1397, INSERM U1060, Lyon 1 University, INSA Lyon), Bâtiment CENS ELI-2D, Pierre-Bénite, France
| | - Audrey Jalabert
- CarMeN Laboratory (INRAe U1397, INSERM U1060, Lyon 1 University, INSA Lyon), Bâtiment CENS ELI-2D, Pierre-Bénite, France
| | - Emmanuelle Meugnier
- CarMeN Laboratory (INRAe U1397, INSERM U1060, Lyon 1 University, INSA Lyon), Bâtiment CENS ELI-2D, Pierre-Bénite, France
| | - Oscar P.B. Wiklander
- Department of Laboratory Medicine, Division of Biomolecular and Cellular Medicine, Karolinska Institutet, 141 57 Huddinge, Sweden
| | - Juliette Jouhet
- Laboratoire de Physiologie Cellulaire & Végétale (LPCV), CNRS (UMR5168)/Université Grenoble Alpes/INRAe (UMR1417)/CEA Grenoble, Institut de Biosciences et Biotechnologies de Grenoble, France
| | | | - Stéphanie Chanon
- CarMeN Laboratory (INRAe U1397, INSERM U1060, Lyon 1 University, INSA Lyon), Bâtiment CENS ELI-2D, Pierre-Bénite, France
| | - Dhanu Gupta
- Department of Laboratory Medicine, Division of Biomolecular and Cellular Medicine, Karolinska Institutet, 141 57 Huddinge, Sweden
| | - Gilles J.P. Rautureau
- Université de Lyon, CNRS, Université Claude Bernard Lyon 1, ENS de Lyon, Centre de RMN à Très Hauts Champs (CRMN), FRE 2034, Villeurbanne, France
| | - Alain Geloen
- CarMeN Laboratory (INRAe U1397, INSERM U1060, Lyon 1 University, INSA Lyon), Bâtiment CENS ELI-2D, Pierre-Bénite, France
| | - Samir El-Andaloussi
- Department of Laboratory Medicine, Division of Biomolecular and Cellular Medicine, Karolinska Institutet, 141 57 Huddinge, Sweden
| | - Baptiste Panthu
- CarMeN Laboratory (INRAe U1397, INSERM U1060, Lyon 1 University, INSA Lyon), Bâtiment CENS ELI-2D, Pierre-Bénite, France
| | - Jennifer Rieusset
- CarMeN Laboratory (INRAe U1397, INSERM U1060, Lyon 1 University, INSA Lyon), Bâtiment CENS ELI-2D, Pierre-Bénite, France
| | - Sophie Rome
- CarMeN Laboratory (INRAe U1397, INSERM U1060, Lyon 1 University, INSA Lyon), Bâtiment CENS ELI-2D, Pierre-Bénite, France
| |
Collapse
|
17
|
Bouchet M, Lainé A, Boyault C, Proponnet-Guerault M, Meugnier E, Bouazza L, Kan CWS, Geraci S, El-Moghrabi S, Hernandez-Vargas H, Benetollo C, Yoshiko Y, Duterque-Coquillaud M, Clézardin P, Marie JC, Bonnelye E. ERRα Expression in Bone Metastases Leads to an Exacerbated Antitumor Immune Response. Cancer Res 2020; 80:2914-2926. [PMID: 32366476 DOI: 10.1158/0008-5472.can-19-3584] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2019] [Revised: 03/20/2020] [Accepted: 04/28/2020] [Indexed: 11/16/2022]
Abstract
Bone is the most common metastatic site for breast cancer. Although the estrogen-related receptor alpha (ERRα) has been implicated in breast cancer cell dissemination to the bone from the primary tumor, its role after tumor cell anchorage in the bone microenvironment remains elusive. Here, we reveal that ERRα inhibits the progression of bone metastases of breast cancer cells by increasing the immune activity of the bone microenvironment. Overexpression of ERRα in breast cancer bone metastases induced expression of chemokines CCL17 and CCL20 and repressed production of TGFβ3. Subsequently, CD8+ T lymphocytes recruited to bone metastases escaped TGFβ signaling control and were endowed with exacerbated cytotoxic features, resulting in significant reduction in metastases. The clinical relevance of our findings in mice was confirmed in over 240 patients with breast cancer. Thus, this study reveals that ERRα regulates immune properties in the bone microenvironment that contributes to decreasing metastatic growth. SIGNIFICANCE: This study places ERRα at the interplay between the immune response and bone metastases of breast cancer, highlighting a potential target for intervention in advanced disease.
Collapse
Affiliation(s)
- Mathilde Bouchet
- INSERM-UMR1033, Labex DEVweCAN, Lyon, France
- University of Lyon-France
| | - Alexandra Lainé
- University of Lyon-France
- Tumor Escape Resistance and Immunity Department, CRCL, INSERM 1052 CNRS 5286, Centre Léon Bérard, Labex DEVweCAN, Lyon, France
| | - Cyril Boyault
- Institute for Advanced Biosciences, UMR5209-INSERM1302, La Tronche, France
| | | | | | - Lamia Bouazza
- INSERM-UMR1033, Labex DEVweCAN, Lyon, France
- University of Lyon-France
| | - Casina W S Kan
- INSERM-UMR1033, Labex DEVweCAN, Lyon, France
- University of Lyon-France
| | - Sandra Geraci
- INSERM-UMR1033, Labex DEVweCAN, Lyon, France
- University of Lyon-France
| | | | - Hector Hernandez-Vargas
- Tumor Escape Resistance and Immunity Department, CRCL, INSERM 1052 CNRS 5286, Centre Léon Bérard, Labex DEVweCAN, Lyon, France
| | - Claire Benetollo
- University of Lyon-France
- INSERM-UMR5292 INSERM U1028, Lyon, France
| | - Yuji Yoshiko
- Department of Calcified Tissue Biology, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, Japan
| | | | | | - Julien C Marie
- University of Lyon-France.
- Tumor Escape Resistance and Immunity Department, CRCL, INSERM 1052 CNRS 5286, Centre Léon Bérard, Labex DEVweCAN, Lyon, France
| | - Edith Bonnelye
- INSERM-UMR1033, Labex DEVweCAN, Lyon, France.
- University of Lyon-France
| |
Collapse
|
18
|
Robert C, Buisson C, Couëdelo L, Meugnier E, Knibbe C, Loizon E, Fonseca L, Laugerette F, Vaysse C, Michalski MC. Differential Metabolic Impact of Natural Food-Grade Emulsifiers Rich in Alpha-Linolenic Acid. Curr Dev Nutr 2020. [DOI: 10.1093/cdn/nzaa045_094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Objectives
Dietary synthetic emulsifiers have recently been shown to promote metabolic syndrome and considerably alter gut microbiota. Conversely, natural emulsifiers such as milk polar lipids (PL) are associated with beneficial metabolic effects. The effects of plant PL remain, however, poorly described. Our objective was to evaluate, using two complimentary rodent models, the impact of nutritional doses of lecithin (≤10%) of vegetal sources alternative to soy on gut microbiota, postprandial lipid metabolism, and the bioavailability of an essential plant lipid, alpha-linolenic acid (ALA).
Methods
For 5 days, male Swiss mice (n = 60) were fed normolipidic diets (identical ALA content) containing 0, 1, 3 or 10% rapeseed lecithin (RL) or 10% soy lecithin. Following an overnight fast, the mice were force-fed the same oil mix and euthanised after 90 min. As a mechanistic study, male Wistar rats (n = 30) with mesenteric duct cannulation were fed 5 oil mixtures containing 0 to 20% RL. Lymph fractions were collected up to 6 h post-gavage. Plasma and lymph lipid composition was determined using GC-FID, chylomicron (CM) size using light-scattering spectroscopy, and intestinal gene expression and faecal microbiota composition by RT-qPCR.
Results
In mice, the consumption of lecithin significantly increased levels of faecal Clostridium leptum (P < 0.001), regardless of lecithin origin or dose. The partial replacement of oil with lecithin did not significantly alter plasma total lipids nor the expression of genes of intestinal lipid absorption. The percentage of ALA in plasma triglycerides was significantly higher in the 10% RL group compared to other groups (P < 0.05). In rats, RL significantly and dose-dependently increased the rate of appearance (P < 0.01) and concentration of ALA in lymph (P < 0.01). 20% RL additionally increased CM size and expression of genes of CM secretion (Mttp, Sar1b; P < 0.05).
Conclusions
Our results reveal that, whereas both rapeseed and soy lecithin improved gut microbiota composition by increasing the anti-inflammatory Clostridium leptum bacterial group, only rapeseed lecithin enhanced ALA bioavailability. This study illustrates the importance of considering the use of natural emulsifiers, especially rapeseed lecithin, as plant-based food ingredients with potential health benefits.
Funding Sources
ANRT and UMT ACTIA BALI.
Collapse
Affiliation(s)
- Chloe Robert
- ITERG, CarMeN Laboratory, INRAE, INSERM, Université Claude Bernard Lyon 1, INSA-Lyon
| | - Charline Buisson
- CarMeN laboratory, INRAE, INSERM, Université Claude Bernard Lyon 1, INSA-Lyon
| | | | - Emmanuelle Meugnier
- CarMeN laboratory, INRAE, INSERM, Université Claude Bernard Lyon 1, INSA-Lyon
| | - Carole Knibbe
- Inria “Beagle” team, CarMeN laboratory, INRAE, INSERM, Université Claude Bernard Lyon 1, INSA-Lyon
| | - Emmanuelle Loizon
- CarMeN laboratory, INRAE, INSERM, Université Claude Bernard Lyon 1, INSA-Lyon
| | | | - Fabienne Laugerette
- CarMeN laboratory, INRAE, INSERM, Université Claude Bernard Lyon 1, INSA-Lyon
| | | | | |
Collapse
|
19
|
Chazarin B, Ziemianin A, Evans AL, Meugnier E, Loizon E, Chery I, Arnemo JM, Swenson JE, Gauquelin-Koch G, Simon C, Blanc S, Lefai E, Bertile F. Limited Oxidative Stress Favors Resistance to Skeletal Muscle Atrophy in Hibernating Brown Bears ( Ursus Arctos). Antioxidants (Basel) 2019; 8:antiox8090334. [PMID: 31443506 PMCID: PMC6770786 DOI: 10.3390/antiox8090334] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2019] [Revised: 08/18/2019] [Accepted: 08/21/2019] [Indexed: 12/14/2022] Open
Abstract
Oxidative stress, which is believed to promote muscle atrophy, has been reported to occur in a few hibernators. However, hibernating bears exhibit efficient energy savings and muscle protein sparing, despite long-term physical inactivity and fasting. We hypothesized that the regulation of the oxidant/antioxidant balance and oxidative stress could favor skeletal muscle maintenance in hibernating brown bears. We showed that increased expressions of cold-inducible proteins CIRBP and RBM3 could favor muscle mass maintenance and alleviate oxidative stress during hibernation. Downregulation of the subunits of the mitochondrial electron transfer chain complexes I, II, and III, and antioxidant enzymes, possibly due to the reduced mitochondrial content, indicated a possible reduction of the production of reactive oxygen species in the hibernating muscle. Concomitantly, the upregulation of cytosolic antioxidant systems, under the control of the transcription factor NRF2, and the maintenance of the GSH/GSSG ratio suggested that bear skeletal muscle is not under a significant oxidative insult during hibernation. Accordingly, lower levels of oxidative damage were recorded in hibernating bear skeletal muscles. These results identify mechanisms by which limited oxidative stress may underlie the resistance to skeletal muscle atrophy in hibernating brown bears. They may constitute therapeutic targets for the treatment of human muscle atrophy.
Collapse
Affiliation(s)
- Blandine Chazarin
- Université de Strasbourg, CNRS, IPHC UMR 7178, F-670000 Strasbourg, France
- Centre National d'Etudes Spatiales, CNES, F-75001 Paris, France
| | - Anna Ziemianin
- Université de Strasbourg, CNRS, IPHC UMR 7178, F-670000 Strasbourg, France
- Centre National d'Etudes Spatiales, CNES, F-75001 Paris, France
| | - Alina L Evans
- Department of Forestry and Wildlife Management, Inland Norway University of Applied Sciences, Campus Evenstad, NO-2480 Koppang, Norway
| | - Emmanuelle Meugnier
- CarMen Laboratory, INSERM 1060, INRA 1397, University of Lyon, F-69600 Oullins, France
| | - Emmanuelle Loizon
- CarMen Laboratory, INSERM 1060, INRA 1397, University of Lyon, F-69600 Oullins, France
| | - Isabelle Chery
- Université de Strasbourg, CNRS, IPHC UMR 7178, F-670000 Strasbourg, France
| | - Jon M Arnemo
- Department of Forestry and Wildlife Management, Inland Norway University of Applied Sciences, Campus Evenstad, NO-2480 Koppang, Norway
- Department of Wildlife, Fish, and Environmental Studies, Swedish University of Agricultural Sciences, SE-901 83 Umeå, Sweden
| | - Jon E Swenson
- Faculty of Environmental Sciences and Natural Resource Management, Norwegian University of Life Sciences, NO-1432 Ås, Norway
- Norwegian Institute for Nature Research, NO-7485 Trondheim, Norway
| | | | - Chantal Simon
- CarMen Laboratory, INSERM 1060, INRA 1397, University of Lyon, F-69600 Oullins, France
| | - Stéphane Blanc
- Université de Strasbourg, CNRS, IPHC UMR 7178, F-670000 Strasbourg, France
| | - Etienne Lefai
- CarMen Laboratory, INSERM 1060, INRA 1397, University of Lyon, F-69600 Oullins, France
- Université d'Auvergne, INRA, UNH UMR1019, F-63122 Saint-Genès Champanelle, France
| | - Fabrice Bertile
- Université de Strasbourg, CNRS, IPHC UMR 7178, F-670000 Strasbourg, France.
| |
Collapse
|
20
|
Milard M, Penhoat A, Durand A, Buisson C, Loizon E, Meugnier E, Bertrand K, Joffre F, Cheillan D, Garnier L, Viel S, Laugerette F, Michalski MC. Acute effects of milk polar lipids on intestinal tight junction expression: towards an impact of sphingomyelin through the regulation of IL-8 secretion? J Nutr Biochem 2019; 65:128-138. [DOI: 10.1016/j.jnutbio.2018.12.007] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2018] [Revised: 10/30/2018] [Accepted: 12/12/2018] [Indexed: 02/07/2023]
|
21
|
Segrestin B, Moreno-Navarrete JM, Seyssel K, Alligier M, Meugnier E, Nazare JA, Vidal H, Fernandez-Real JM, Laville M. Adipose Tissue Expansion by Overfeeding Healthy Men Alters Iron Gene Expression. J Clin Endocrinol Metab 2019; 104:688-696. [PMID: 30260393 DOI: 10.1210/jc.2018-01169] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/01/2018] [Accepted: 09/20/2018] [Indexed: 02/13/2023]
Abstract
CONTEXT Iron overload has been associated with greater adipose tissue (AT) depots. We retrospectively studied the potential interactions between iron and AT during an experimental overfeeding in participants without obesity. METHODS Twenty-six participants (mean body mass index ± SD, 24.7 ± 3.1 kg/m2) underwent a 56-day overfeeding (+760 kcal/d). Serum iron biomarkers (ELISA), subcutaneous AT (SAT) gene expression, and abdominal AT distribution assessed by MRI were analyzed at the beginning and the end of the intervention. RESULTS Before intervention: SAT mRNA expression of the iron transporter transferrin (Tf) was positively correlated with the expression of genes related to lipogenesis (lipin 1, ACSL1) and lipid storage (SCD). SAT expression of the ferritin light chain (FTL) gene, encoding ferritin (FT), an intracellular iron storage protein, was negatively correlated to SREBF1, a gene related to lipogenesis. Serum FT (mean, 92 ± 57 ng/mL) was negatively correlated with the expression of SAT genes linked to lipid storage (SCD, DGAT2) and to lipogenesis (SREBF1, ACSL1). After intervention: Overfeeding led to a 2.3 ± 1.3-kg weight gain. In parallel to increased expression of lipid storage-related genes (mitoNEET, SCD, DGAT2, SREBF1), SAT Tf, SLC40A1 (encoding ferroportin 1, a membrane iron export channel) and hephaestin mRNA levels increased, whereas SAT FTL mRNA decreased, suggesting increased AT iron requirement. Serum FT decreased to 67 ± 43 ng/mL. However, no significant associations between serum iron biomarkers and AT distribution or expansion were observed. CONCLUSION In healthy men, iron metabolism gene expression in SAT is associated with lipid storage and lipogenesis genes expression and is modulated during a 56-day overfeeding diet.
Collapse
Affiliation(s)
- Berenice Segrestin
- Univ-Lyon, CarMeN Laboratory, and Centre de Recherche en Nutrition Humaine Rhône-Alpes, Université Claude Bernard Lyon1, Pierre Benite, France
- Eating Disorder Unit, Groupe Hospitalier Est, Hospices Civils de Lyon, Bron, France
| | - José Maria Moreno-Navarrete
- Department of Diabetes, Endocrinology and Nutrition, Girona Biomedical Research Institute, Hospital Universitari de Girona Dr Josep Trueta, Departament de Medicina, Universitat de Girona, CIBER Fisiopatologia de la Obesidad y Nutricion, Girona, Spain
| | - Kevin Seyssel
- Univ-Lyon, CarMeN Laboratory, and Centre de Recherche en Nutrition Humaine Rhône-Alpes, Université Claude Bernard Lyon1, Pierre Benite, France
| | - Maud Alligier
- Univ-Lyon, CarMeN Laboratory, and Centre de Recherche en Nutrition Humaine Rhône-Alpes, Université Claude Bernard Lyon1, Pierre Benite, France
- F-CRIN/FORCE Network, Pierre Bénite, France
| | - Emmanuelle Meugnier
- Univ-Lyon, CarMeN Laboratory, and Centre de Recherche en Nutrition Humaine Rhône-Alpes, Université Claude Bernard Lyon1, Pierre Benite, France
| | - Julie-Anne Nazare
- Univ-Lyon, CarMeN Laboratory, and Centre de Recherche en Nutrition Humaine Rhône-Alpes, Université Claude Bernard Lyon1, Pierre Benite, France
| | - Hubert Vidal
- Univ-Lyon, CarMeN Laboratory, and Centre de Recherche en Nutrition Humaine Rhône-Alpes, Université Claude Bernard Lyon1, Pierre Benite, France
| | - José Manuel Fernandez-Real
- Department of Diabetes, Endocrinology and Nutrition, Girona Biomedical Research Institute, Hospital Universitari de Girona Dr Josep Trueta, Departament de Medicina, Universitat de Girona, CIBER Fisiopatologia de la Obesidad y Nutricion, Girona, Spain
| | - Martine Laville
- Univ-Lyon, CarMeN Laboratory, and Centre de Recherche en Nutrition Humaine Rhône-Alpes, Université Claude Bernard Lyon1, Pierre Benite, France
- Endocrinology, Diabetes, and Nutrition Department, Groupe Hospitalier Sud, Hospices Civils de Lyon, Pierre Benite, France
- F-CRIN/FORCE Network, Pierre Bénite, France
| |
Collapse
|
22
|
Milard M, Laugerette F, Durand A, Buisson C, Meugnier E, Loizon E, Louche-Pelissier C, Sauvinet V, Garnier L, Viel S, Bertrand K, Joffre F, Cheillan D, Humbert L, Rainteau D, Plaisancié P, Bindels LB, Neyrinck AM, Delzenne NM, Michalski MC. Front cover: Milk Polar Lipids in a High-Fat Diet Can Prevent Body Weight Gain: Modulated Abundance of Gut Bacteria in Relation with Fecal Loss of Specific Fatty Acids. Mol Nutr Food Res 2019. [DOI: 10.1002/mnfr.201970010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
23
|
Milard M, Laugerette F, Durand A, Buisson C, Meugnier E, Loizon E, Louche-Pelissier C, Sauvinet V, Garnier L, Viel S, Bertrand K, Joffre F, Cheillan D, Humbert L, Rainteau D, Plaisancié P, Bindels LB, Neyrinck AM, Delzenne NM, Michalski MC. Milk Polar Lipids in a High-Fat Diet Can Prevent Body Weight Gain: Modulated Abundance of Gut Bacteria in Relation with Fecal Loss of Specific Fatty Acids. Mol Nutr Food Res 2019; 63:e1801078. [DOI: 10.1002/mnfr.201801078] [Citation(s) in RCA: 29] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2018] [Revised: 12/18/2018] [Indexed: 01/14/2023]
Affiliation(s)
- Marine Milard
- Univ Lyon; CarMeN Laboratory; INSERM U1060; INRA U1397; INSA Lyon; Université Claude Bernard Lyon 1; 69621 Villeurbanne France
| | - Fabienne Laugerette
- Univ Lyon; CarMeN Laboratory; INSERM U1060; INRA U1397; INSA Lyon; Université Claude Bernard Lyon 1; 69621 Villeurbanne France
| | - Annie Durand
- Univ Lyon; CarMeN Laboratory; INSERM U1060; INRA U1397; INSA Lyon; Université Claude Bernard Lyon 1; 69621 Villeurbanne France
| | - Charline Buisson
- Univ Lyon; CarMeN Laboratory; INSERM U1060; INRA U1397; INSA Lyon; Université Claude Bernard Lyon 1; 69621 Villeurbanne France
| | - Emmanuelle Meugnier
- Univ Lyon; CarMeN Laboratory; INSERM; INRA; INSA Lyon; Université Claude Bernard Lyon 1; 69600 Oullins France
| | - Emmanuelle Loizon
- Univ Lyon; CarMeN Laboratory; INSERM; INRA; INSA Lyon; Université Claude Bernard Lyon 1; 69600 Oullins France
| | - Corinne Louche-Pelissier
- Centre de Recherche en Nutrition Humaine (CRNH) Rhône-Alpes; Centre Européen Pour la Nutrition et la Santé; Centre Hospitalier Lyon Sud; Université Claude Bernard Lyon 1; INSERM, Hospices Civils de Lyon F-69310 Pierre Bénite France
| | - Valérie Sauvinet
- Centre de Recherche en Nutrition Humaine (CRNH) Rhône-Alpes; Centre Européen Pour la Nutrition et la Santé; Centre Hospitalier Lyon Sud; Université Claude Bernard Lyon 1; INSERM, Hospices Civils de Lyon F-69310 Pierre Bénite France
| | - Lorna Garnier
- Laboratoire d'Immunologie; Hospices Civils de Lyon; Centre Hospitalier Lyon Sud; Pierre-Bénite France
| | - Sébastien Viel
- Laboratoire d'Immunologie; Hospices Civils de Lyon; Centre Hospitalier Lyon Sud; Pierre-Bénite France
| | | | | | - David Cheillan
- Univ Lyon; CarMeN Laboratory; INSERM U1060; INRA U1397; INSA Lyon; Université Claude Bernard Lyon 1; 69621 Villeurbanne France
- Service Biochimie et Biologie Moléculaire Grand Est; Centre de Biologie Est; Hospices Civils de Lyon; Lyon France
| | - Lydie Humbert
- Sorbonne Universités; UPMC Univ. Paris 06; École normale supérieure; PSL Research University; CNRS, INSERM, APHP, Laboratoire des Biomolécules (LBM), 27 rue de Chaligny Paris 75005 France
| | - Dominique Rainteau
- Sorbonne Universités; UPMC Univ. Paris 06; École normale supérieure; PSL Research University; CNRS, INSERM, APHP, Laboratoire des Biomolécules (LBM), 27 rue de Chaligny Paris 75005 France
| | - Pascale Plaisancié
- Univ Lyon; CarMeN Laboratory; INSERM U1060; INRA U1397; INSA Lyon; Université Claude Bernard Lyon 1; 69621 Villeurbanne France
| | - Laure B. Bindels
- Louvain Drug Research Institute; Metabolism and Nutrition Research Group; Université catholique de Louvain; Brussels Belgium
| | - Audrey M. Neyrinck
- Louvain Drug Research Institute; Metabolism and Nutrition Research Group; Université catholique de Louvain; Brussels Belgium
| | - Nathalie M. Delzenne
- Louvain Drug Research Institute; Metabolism and Nutrition Research Group; Université catholique de Louvain; Brussels Belgium
| | - Marie-Caroline Michalski
- Univ Lyon; CarMeN Laboratory; INSERM U1060; INRA U1397; INSA Lyon; Université Claude Bernard Lyon 1; 69621 Villeurbanne France
| |
Collapse
|
24
|
Morigny P, Houssier M, Mairal A, Ghilain C, Mouisel E, Benhamed F, Masri B, Recazens E, Denechaud PD, Tavernier G, Caspar-Bauguil S, Virtue S, Sramkova V, Monbrun L, Mazars A, Zanoun M, Guilmeau S, Barquissau V, Beuzelin D, Bonnel S, Marques M, Monge-Roffarello B, Lefort C, Fielding B, Sulpice T, Astrup A, Payrastre B, Bertrand-Michel J, Meugnier E, Ligat L, Lopez F, Guillou H, Ling C, Holm C, Rabasa-Lhoret R, Saris WHM, Stich V, Arner P, Rydén M, Moro C, Viguerie N, Harms M, Hallén S, Vidal-Puig A, Vidal H, Postic C, Langin D. Interaction between hormone-sensitive lipase and ChREBP in fat cells controls insulin sensitivity. Nat Metab 2019; 1:133-146. [PMID: 32694809 DOI: 10.1038/s42255-018-0007-6] [Citation(s) in RCA: 31] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/15/2018] [Accepted: 10/24/2018] [Indexed: 02/08/2023]
Abstract
Impaired adipose tissue insulin signalling is a critical feature of insulin resistance. Here we identify a pathway linking the lipolytic enzyme hormone-sensitive lipase (HSL) to insulin action via the glucose-responsive transcription factor ChREBP and its target, the fatty acid elongase ELOVL6. Genetic inhibition of HSL in human adipocytes and mouse adipose tissue results in enhanced insulin sensitivity and induction of ELOVL6. ELOVL6 promotes an increase in phospholipid oleic acid, which modifies plasma membrane fluidity and enhances insulin signalling. HSL deficiency-mediated effects are suppressed by gene silencing of ChREBP and ELOVL6. Mechanistically, physical interaction between HSL, independent of lipase activity, and the isoform activated by glucose metabolism ChREBPα impairs ChREBPα translocation into the nucleus and induction of ChREBPβ, the isoform with high transcriptional activity that is strongly associated with whole-body insulin sensitivity. Targeting the HSL-ChREBP interaction may allow therapeutic strategies for the restoration of insulin sensitivity.
Collapse
Affiliation(s)
- Pauline Morigny
- Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France
- University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France
| | - Marianne Houssier
- Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France
- University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France
| | - Aline Mairal
- Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France
- University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France
| | - Claire Ghilain
- Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France
- University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France
| | - Etienne Mouisel
- Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France
- University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France
| | - Fadila Benhamed
- Institut National de la Santé et de la Recherche Médicale (Inserm), U1016, Institut Cochin, Paris, France
- Centre National de la Recherche Scientifique (CNRS), UMR 8104, Paris, France
- Université Paris Descartes, Sorbonne Paris Cité, Paris, France
| | - Bernard Masri
- Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France
- University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France
| | - Emeline Recazens
- Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France
- University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France
| | - Pierre-Damien Denechaud
- Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France
- University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France
| | - Geneviève Tavernier
- Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France
- University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France
| | - Sylvie Caspar-Bauguil
- Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France
- University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France
- Toulouse University Hospitals, Laboratory of Clinical Biochemistry, Toulouse, France
| | - Sam Virtue
- University of Cambridge Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK
| | - Veronika Sramkova
- Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France
- University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France
- Department for the Study of Obesity and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czech Republic
- Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague and Paul Sabatier University, Toulouse, France
| | - Laurent Monbrun
- Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France
- University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France
| | - Anne Mazars
- Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France
- University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France
| | - Madjid Zanoun
- Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France
- University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France
| | - Sandra Guilmeau
- Institut National de la Santé et de la Recherche Médicale (Inserm), U1016, Institut Cochin, Paris, France
- Centre National de la Recherche Scientifique (CNRS), UMR 8104, Paris, France
- Université Paris Descartes, Sorbonne Paris Cité, Paris, France
| | - Valentin Barquissau
- Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France
- University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France
| | - Diane Beuzelin
- Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France
- University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France
| | - Sophie Bonnel
- Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France
- University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France
- Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague and Paul Sabatier University, Toulouse, France
| | - Marie Marques
- Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France
- University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France
- Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague and Paul Sabatier University, Toulouse, France
| | - Boris Monge-Roffarello
- Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France
- University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France
| | - Corinne Lefort
- Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France
- University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France
| | - Barbara Fielding
- Department of Nutritional Sciences, University of Surrey, Guildford, Surrey, UK
| | | | - Arne Astrup
- Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark
| | - Bernard Payrastre
- Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France
- University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France
| | - Justine Bertrand-Michel
- Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France
- University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France
| | - Emmanuelle Meugnier
- CarMeN Laboratory, Inserm U1060, INRA U1397, Université Lyon 1, INSA Lyon, Oullins, France
| | - Laetitia Ligat
- Pôle Technologique, Cancer Research Center of Toulouse (CRCT), Plateau Interactions Moléculaires, INSERM-UMR1037, Toulouse, France
| | - Frédéric Lopez
- Pôle Technologique, Cancer Research Center of Toulouse (CRCT), Plateau Interactions Moléculaires, INSERM-UMR1037, Toulouse, France
| | - Hervé Guillou
- Institut National de la Recherche Agronomique (INRA), UMR1331, Integrative Toxicology and Metabolism, Toulouse, France
- University of Toulouse, UMR1331, Institut National Polytechnique (INP), Paul Sabatier University, Toulouse, France
| | - Charlotte Ling
- Department of Clinical Sciences, Epigenetics and Diabetes, Lund University Diabetes Centre, Clinical Research Centre, Malmö, Sweden
| | - Cecilia Holm
- Department of Experimental Medical Science, Lund University, Biomedical Centre, Lund, Sweden
| | - Remi Rabasa-Lhoret
- Institut de Recherches Cliniques de Montréal, Montreal, Canada
- Department of nutrition, Université de Montréal, Montreal, Canada
- Montreal Diabetes Research Center (MDRC), Montreal, Canada
| | - Wim H M Saris
- Department of Human Biology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre, Maastricht, the Netherlands
| | - Vladimir Stich
- Department for the Study of Obesity and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czech Republic
- Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague and Paul Sabatier University, Toulouse, France
| | - Peter Arner
- Department of Medicine, H7, Karolinska Institutet and Karolinska University Hospital, Huddinge, Stockholm, Sweden
| | - Mikael Rydén
- Department of Medicine, H7, Karolinska Institutet and Karolinska University Hospital, Huddinge, Stockholm, Sweden
| | - Cedric Moro
- Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France
- University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France
- Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague and Paul Sabatier University, Toulouse, France
| | - Nathalie Viguerie
- Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France
- University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France
- Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague and Paul Sabatier University, Toulouse, France
| | - Matthew Harms
- Cardiovascular, Renal and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden
| | - Stefan Hallén
- Cardiovascular, Renal and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden
| | - Antonio Vidal-Puig
- University of Cambridge Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK
- Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, UK
| | - Hubert Vidal
- CarMeN Laboratory, Inserm U1060, INRA U1397, Université Lyon 1, INSA Lyon, Oullins, France
| | - Catherine Postic
- Institut National de la Santé et de la Recherche Médicale (Inserm), U1016, Institut Cochin, Paris, France
- Centre National de la Recherche Scientifique (CNRS), UMR 8104, Paris, France
- Université Paris Descartes, Sorbonne Paris Cité, Paris, France
| | - Dominique Langin
- Institut National de la Santé et de la Recherche Médicale (Inserm), UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France.
- University of Toulouse, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Paul Sabatier University, Toulouse, France.
- Toulouse University Hospitals, Laboratory of Clinical Biochemistry, Toulouse, France.
- Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague and Paul Sabatier University, Toulouse, France.
| |
Collapse
|
25
|
Segrestin B, Seyssel K, Alligier M, Meugnier E, Nazare JA, Vidal H, Fernandez Real J, Moreno Navarrete J, Laville M. La ferritine plasmatique module l’expression des gènes du tissu adipeux sous-cutané chez l’homme. NUTR CLIN METAB 2018. [DOI: 10.1016/j.nupar.2018.09.164] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
26
|
Galusca B, Verney J, Meugnier E, Ling Y, Edouard P, Feasson L, Ravelojaona M, Vidal H, Estour B, Germain N. Reduced fibre size, capillary supply and mitochondrial activity in constitutional thinness' skeletal muscle. Acta Physiol (Oxf) 2018; 224:e13097. [PMID: 29754437 DOI: 10.1111/apha.13097] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2018] [Revised: 05/07/2018] [Accepted: 05/08/2018] [Indexed: 11/30/2022]
Abstract
AIM Constitutional thinness (CT) is a rare condition of natural low body weight, with no psychological issues, no marker of undernutrition and a resistance to weight gain. This study evaluated the skeletal muscle phenotype of CT women by comparison with a normal BMI control group. METHODS Ten CT women (BMI < 17.5 kg/m2 ) and 10 female controls (BMI: 18.5-25 kg/m2 ) underwent metabolic and hormonal assessment along with muscle biopsies to analyse the skeletal muscular fibres pattern, capillarity, enzymes activities and transcriptomics. RESULTS Constitutional thinness displayed similar energy balance metabolic and hormonal profile to controls. Constitutional thinness presented with lower mean area of all the skeletal muscular fibres (-24%, P = .01) and percentage of slow-twitch type I fibres (-25%, P = .02, respectively). Significant downregulation of the mRNA expression of several mitochondrial-related genes and triglycerides metabolism was found along with low cytochrome c oxidase (COX) activity and capillary network in type I fibres. Pre- and post-mitochondrial respiratory chain enzymes levels were found similar to controls. Transcriptomics also revealed downregulation of cytoskeletal-related genes. CONCLUSION Diminished type I fibres, decreased mitochondrial and metabolic activity suggested by these results are discordant with normal resting metabolic rate of CT subjects. Downregulated genes related to cytoskeletal proteins and myocyte differentiation could account for CT's resistance to weight gain.
Collapse
Affiliation(s)
- B. Galusca
- Division of Endocrinology, Diabetes, Metabolism and Eating Disorders; CHU Saint-Etienne; Saint-Etienne France
- Eating Disorders, Addictions & Extreme Bodyweight Research Group (TAPE) EA 7423; Jean Monnet University; Saint-Etienne France
| | - J. Verney
- Interuniversity Laboratory of Motricity & Biology (LIBM) EA 7424; Jean Monnet University; Saint-Etienne France
- Laboratory of Metabolic Adaptations to Exercise in Physiological and Pathological conditions (AME2P) EA 3533; Blaise Pascal University; Clermont-Ferrand France
| | - E. Meugnier
- CarMeN Laboratory, INSERM U1060, INRA U1397; INSA-Lyon, Faculté de Médecine Lyon-Sud; Université Lyon 1; Lyon University; Oullins France
| | - Y. Ling
- Eating Disorders, Addictions & Extreme Bodyweight Research Group (TAPE) EA 7423; Jean Monnet University; Saint-Etienne France
| | - P. Edouard
- Interuniversity Laboratory of Motricity & Biology (LIBM) EA 7424; Jean Monnet University; Saint-Etienne France
| | - L. Feasson
- Interuniversity Laboratory of Motricity & Biology (LIBM) EA 7424; Jean Monnet University; Saint-Etienne France
| | - M. Ravelojaona
- Interuniversity Laboratory of Motricity & Biology (LIBM) EA 7424; Jean Monnet University; Saint-Etienne France
| | - H. Vidal
- CarMeN Laboratory, INSERM U1060, INRA U1397; INSA-Lyon, Faculté de Médecine Lyon-Sud; Université Lyon 1; Lyon University; Oullins France
| | - B. Estour
- Division of Endocrinology, Diabetes, Metabolism and Eating Disorders; CHU Saint-Etienne; Saint-Etienne France
- Eating Disorders, Addictions & Extreme Bodyweight Research Group (TAPE) EA 7423; Jean Monnet University; Saint-Etienne France
| | - N. Germain
- Division of Endocrinology, Diabetes, Metabolism and Eating Disorders; CHU Saint-Etienne; Saint-Etienne France
- Eating Disorders, Addictions & Extreme Bodyweight Research Group (TAPE) EA 7423; Jean Monnet University; Saint-Etienne France
| |
Collapse
|
27
|
Milard M, Laugerette F, Bugeat S, Plaisancié P, Létisse M, Meugnier E, Loizon E, Durand A, Buisson C, Géloën A, Serieye S, Michalski MC. Metabolic effects in mice of cream formulation: Addition of both thickener and emulsifier does not alter lipid metabolism but modulates mucus cells and intestinal endoplasmic reticulum stress. J Dairy Sci 2018; 101:10649-10663. [PMID: 30316592 DOI: 10.3168/jds.2018-14783] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2018] [Accepted: 08/21/2018] [Indexed: 12/19/2022]
Abstract
Additives stabilize or improve the organoleptic or functional properties (or both) of many dairy products including whipping cream. Their influence on the metabolic effect of dairy cream is scarcely known. We tested the hypothesis that added emulsifier (lactic acid esters of mono- and diglycerides; MAG/DAG), thickener (carrageenan, CGN), or both, could modify the metabolic effect, notably in the intestine and liver. Nine-week-old male C57Bl/6J mice were fed UHT cream (indirect treatment) mixed with nonlipidic powder (final: 13% milkfat) for 1 or 4 wk. We compared creams (1) without additive (Ctl), (2) with thickener (Th), 0.02% of κ-CGN, and (3) with both thickener and emulsifier, 0.1% of MAG/DAG esters (Th/Em). We analyzed plasma parameters, intestine, and liver. Fasting glycemia, insulinemia, triglyceridemia, nonesterified fatty acids, body weight gain, and liver weight did not differ among groups. After 1 wk, Th/Em had higher expression in the duodenum of some of the genes involved in (1) intestinal lipid absorption and (2) tight junction proteins versus Ctl and Th. After 4 wk, mucus cell number in the small intestine was higher in Th/Em versus Ctl and Th. Genes involved in endoplasmic reticulum (ER) stress in the duodenum were more expressed in Th/Em after 1 wk. After 4 wk, in the colon, a higher expression of ER stress genes was observed for Th versus Th/Em and Ctl. Liver damage score was not altered by additives. Adding both CGN (0.02%) and MAG/DAG esters (0.1%) in dairy cream did not result in deleterious outcomes in mice after 4 wk regarding lipid metabolism, intestinal permeability, and liver disorders. The longer term effect of intestinal ER stress modulation deserves further investigation.
Collapse
Affiliation(s)
- M Milard
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69621 Villeurbanne, France
| | - F Laugerette
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69621 Villeurbanne, France
| | - S Bugeat
- Sodiaal International Research and Innovation Department, Paris, France
| | - P Plaisancié
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69621 Villeurbanne, France
| | - M Létisse
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69621 Villeurbanne, France
| | - E Meugnier
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69600 Oullins, France
| | - E Loizon
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69600 Oullins, France
| | - A Durand
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69621 Villeurbanne, France
| | - C Buisson
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69621 Villeurbanne, France
| | - A Géloën
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69621 Villeurbanne, France
| | - S Serieye
- Sodiaal International Research and Innovation Department, Paris, France
| | - M-C Michalski
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69621 Villeurbanne, France.
| |
Collapse
|
28
|
Milard M, Laugerette F, Bugeat S, Plaisancié P, Létisse M, Meugnier E, Loizon E, Durand A, Buisson C, Géloën A, Serieye S, Michalski MC. Metabolic effects in mice of cream processing: Direct ultra-high-temperature process lowers high-fat-induced adipose tissue inflammation. J Dairy Sci 2018; 101:10636-10648. [PMID: 30316591 DOI: 10.3168/jds.2018-14782] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2018] [Accepted: 08/21/2018] [Indexed: 01/12/2023]
Abstract
Although UHT heat treatment is being optimized to improve the stability and functional properties of dairy products, its metabolic effects remain scarcely known. As such, we studied the effect of the type of UHT process on lipid metabolism, intestinal barrier, and inflammation in mice. Nine-week-old male C57Bl/6J mice were fed a diet composed of nonlipidic powder mixed with different UHT dairy creams (final: 13% milkfat) for 1 or 4 wk. All creams contained 0.02% of thickener (carrageenan) and were treated via either (1) classical indirect heating process (Th), (2) indirect process at higher temperature (Th+), or (3) direct process by steam injection (ThD). Plasma, epididymal adipose tissue (EAT), and intestine were analyzed. Multivariate principal component analyses were used to identify differential effects of processes. Th+ differed by a globally higher liver damage score compared with that of the other creams. After 4 wk, the duodenal expression of lipid absorption genes fatty acid binding protein 4 (Fatp4) and microsomal triglycerides transfer protein (Mttp) was lower in the Th+ versus Th group. Expression in the colon of tight junction protein zonula occludens 1 (Zo1) and of some endoplasmic reticulum stress markers was lower in both Th+ and ThD versus the Th group. In EAT, ThD had lower gene expression of several inflammatory markers after 4 wk. Some differential effects may be related to heat-induced physicochemical changes of creams. The type of cream UHT process differentially affected metabolic parameters in mice after a 4-wk fat-rich diet, partly due to cream structure. Altogether, direct steam injection process induced the lowest early markers of high-fat-induced metabolic inflammation in EAT.
Collapse
Affiliation(s)
- M Milard
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69621 Villeurbanne, France
| | - F Laugerette
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69621 Villeurbanne, France
| | - S Bugeat
- Sodiaal International Research and Innovation Department, Paris, France
| | - P Plaisancié
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69621 Villeurbanne, France
| | - M Létisse
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69621 Villeurbanne, France
| | - E Meugnier
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69600 Oullins, France
| | - E Loizon
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69600 Oullins, France
| | - A Durand
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69621 Villeurbanne, France
| | - C Buisson
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69621 Villeurbanne, France
| | - A Géloën
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69621 Villeurbanne, France
| | - S Serieye
- Sodiaal International Research and Innovation Department, Paris, France
| | - M-C Michalski
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69621 Villeurbanne, France.
| |
Collapse
|
29
|
Cyr Y, Bissonnette S, Lamantia V, Besse-Patin A, Meugnier E, Wabitsch M, Vidal H, Estall JL, Chrétien M, Faraj M. ApoB-lipoproteins and PCSK9 as Modulators of Human White Adipose Tissue Function and NLRP3 Inflammasome Activity. ATHEROSCLEROSIS SUPP 2018. [DOI: 10.1016/j.atherosclerosissup.2018.04.360] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
30
|
Doñate Puertas R, Jalabert A, Meugnier E, Euthine V, Chevalier P, Rome S. Analysis of the microRNA signature in left atrium from patients with valvular heart disease reveals their implications in atrial fibrillation. PLoS One 2018; 13:e0196666. [PMID: 29723239 PMCID: PMC5933750 DOI: 10.1371/journal.pone.0196666] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2017] [Accepted: 04/17/2018] [Indexed: 12/13/2022] Open
Abstract
BACKGROUND Among the potential factors which may contribute to the development and perpetuation of atrial fibrillation, dysregulation of miRNAs has been suggested. Thus in this study, we have quantified the basal expressions of 662 mature human miRNAs in left atrium (LA) from patients undergoing cardiac surgery for valve repair, suffering or not from atrial fibrillation (AF) by using TaqMan® Low Density arrays (v2.0). RESULTS Among the 299 miRNAs expressed in all patients, 42 miRNAs had altered basal expressions in patients with AF. Binding-site predictions with Targetscan (conserved sites among species) indicated that the up- and down-regulated miRNAs controlled respectively 3,310 and 5,868 genes. To identify the most relevant cellular functions under the control of the altered miRNAs, we focused on the 100 most targeted genes of each list and identified 5 functional protein-protein networks among these genes. Up-regulated networks were involved in synchronisation of circadian rythmicity and in the control of the AKT/PKC signaling pathway (i.e., proliferation/adhesion). Down-regulated networks were the IGF-1 pathway and TGF-beta signaling pathway and a network involved in RNA-mediated gene silencing, suggesting for the first time that alteration of miRNAs in AF would also perturbate the whole miRNA machinery. Then we crossed the list of miRNA predicted genes, and the list of mRNAs altered in similar patients suffering from AF and we found that respectively 44.5% and 55% of the up- and down-regulated mRNA are predicted to be conserved targets of the altered miRNAs (at least one binding site in 3'-UTR). As they were involved in the same biological processes mentioned above, these data demonstrated that a great part of the transcriptional defects previously published in LA from AF patients are likely due to defects at the post-transcriptional level and involved the miRNAs. CONCLUSIONS Our stringent analysis permitted us to identify highly targeted protein-protein networks under the control of miRNAs in LA and, among them, to highlight those specifically affected in AF patients with altered miRNA signature. Further studies are now required to determine whether alterations of miRNA levels in AF pathology are causal or represent an adaptation to prevent cardiac electrical and structural remodeling.
Collapse
Affiliation(s)
- Rosa Doñate Puertas
- Institut NeuroMyoGene (INMG), UMR CNRS 5310-INSERM U1217 / University of Lyon, Lyon, France
| | - Audrey Jalabert
- CarMeN Laboratory (UMR INSERM 1060-INRA 1397, INSA), Lyon-Sud Faculty of Medicine, University of Lyon, Pierre-Bénite, France
| | - Emmanuelle Meugnier
- CarMeN Laboratory (UMR INSERM 1060-INRA 1397, INSA), Lyon-Sud Faculty of Medicine, University of Lyon, Pierre-Bénite, France
| | - Vanessa Euthine
- CarMeN Laboratory (UMR INSERM 1060-INRA 1397, INSA), Lyon-Sud Faculty of Medicine, University of Lyon, Pierre-Bénite, France
| | - Philippe Chevalier
- Institut NeuroMyoGene (INMG), UMR CNRS 5310-INSERM U1217 / University of Lyon, Lyon, France
- Rhythmology Unit, Louis Pradel Cardiology Hospital, Hospices Civils de Lyon, Bron, France
- * E-mail: (SR); (PC)
| | - Sophie Rome
- CarMeN Laboratory (UMR INSERM 1060-INRA 1397, INSA), Lyon-Sud Faculty of Medicine, University of Lyon, Pierre-Bénite, France
- * E-mail: (SR); (PC)
| |
Collapse
|
31
|
Herzig KH, Leppäluoto J, Jokelainen J, Meugnier E, Pesenti S, Selänne H, Mäkelä KA, Ahola R, Jämsä T, Vidal H, Keinänen-Kiukaanniemi S. Low level activity thresholds for changes in NMR biomarkers and genes in high risk subjects for Type 2 Diabetes. Sci Rep 2017; 7:11267. [PMID: 28924247 PMCID: PMC5603534 DOI: 10.1038/s41598-017-09753-6] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2017] [Accepted: 07/28/2017] [Indexed: 01/26/2023] Open
Abstract
Our objectives were to determine if there are quantitative associations between amounts and intensities of physical activities (PA) on NMR biomarkers and changes in skeletal muscle gene expressions in subjects with high risk for type 2 diabetes (T2D) performing a 3-month PA intervention. We found that PA was associated with beneficial biomarker changes in a factor containing several VLDL and HDL subclasses and lipids in principal component analysis (P = <0.01). Division of PA into quartiles demonstrated significant changes in NMR biomarkers in the 2nd - 4th quartiles compared to the 1st quartile representing PA of less than 2850 daily steps (P = 0.0036). Mediation analysis of PA-related reductions in lipoproteins showed that the effects of PA was 4-15 times greater than those of body weight or fat mass reductions. In a subset study in highly active subjects' gene expressions of oxidative fiber markers, Apo D, and G0/G1 Switch Gene 2, controlling insulin signaling and glucose metabolism were significantly increased. Slow walking at speeds of 2-3 km/h exceeding 2895 steps/day attenuated several circulating lipoprotein lipids. The effects were mediated rather by PA than body weight or fat loss. Thus, lower thresholds for PA may exist for long term prevention of cardio-metabolic diseases in sedentary overweight subjects.
Collapse
Affiliation(s)
- Karl-Heinz Herzig
- Research Unit of Biomedicine, and Biocenter of Oulu, Oulu University, 90014, Oulu, Finland. .,Department of Gastroenterology and Metabolism, Poznan University of Medical Sciences, Poznan, Poland. .,Medical Research Center and Oulu University Hospital, University of Oulu and Oulu University Hospital, Oulu, Finland.
| | - Juhani Leppäluoto
- Research Unit of Biomedicine, and Biocenter of Oulu, Oulu University, 90014, Oulu, Finland
| | - Jari Jokelainen
- Center for Life Course Health Research, Faculty of Medicine, University of Oulu, 90014, Oulu, Finland.,Oulu University Hospital, Unit of General Practice, and Health Center of Oulu, Oulu, Finland
| | - Emmanuelle Meugnier
- CarMeN Laboratory, INSERM U1060, INRA U1397, University of Lyon, 69600, Oullins, France
| | - Sandra Pesenti
- CarMeN Laboratory, INSERM U1060, INRA U1397, University of Lyon, 69600, Oullins, France
| | - Harri Selänne
- Department of Education and Psychology, University of Jyväskylä, Jyväskylä, Finland
| | - Kari A Mäkelä
- Research Unit of Biomedicine, and Biocenter of Oulu, Oulu University, 90014, Oulu, Finland
| | - Riikka Ahola
- Research Unit of Medical Imaging, Physics and Technology, University of Oulu, 90014, Oulu, Finland
| | - Timo Jämsä
- Medical Research Center and Oulu University Hospital, University of Oulu and Oulu University Hospital, Oulu, Finland.,Research Unit of Medical Imaging, Physics and Technology, University of Oulu, 90014, Oulu, Finland.,Department of Diagnostic Imaging, Oulu University Hospital, Oulu, Finland
| | - Hubert Vidal
- CarMeN Laboratory, INSERM U1060, INRA U1397, University of Lyon, 69600, Oullins, France
| | - Sirkka Keinänen-Kiukaanniemi
- Center for Life Course Health Research, Faculty of Medicine, University of Oulu, 90014, Oulu, Finland.,Oulu University Hospital, Unit of General Practice, and Health Center of Oulu, Oulu, Finland
| |
Collapse
|
32
|
Verney J, Germain N, Meugnier E, Grateau G, Édouard P, Féasson L, Denis C, Ravelojaona M, Vidal H, Estour B, Galusca B. Maigreur constitutionnelle : un phénotype musculaire spécifique. NUTR CLIN METAB 2017. [DOI: 10.1016/j.nupar.2017.06.039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
33
|
Doñate Puertas R, Meugnier E, Romestaing C, Rey C, Morel E, Lachuer J, Gadot N, Scridon A, Julien C, Tronc F, Chapuis B, Valla C, Janin A, Pirola L, Méjat A, Rome S, Chevalier P. Atrial fibrillation is associated with hypermethylation in human left atrium, and treatment with decitabine reduces atrial tachyarrhythmias in spontaneously hypertensive rats. Transl Res 2017; 184:57-67.e5. [PMID: 28427903 DOI: 10.1016/j.trsl.2017.03.004] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/23/2016] [Revised: 03/13/2017] [Accepted: 03/17/2017] [Indexed: 10/19/2022]
Abstract
Atrial fibrillation (AF) is the most common cardiac arrhythmia. As the molecular mechanisms underlying the pathology are largely unknown, this cardiac arrhythmia remains difficult to treat. To identify specific molecular actors involved in AF, we have performed a transcriptomic analysis on left atrium (LA) from patients with valvular heart disease with or without AF. We showed that 1627 genes had altered basal expression level in LA tissue of AF patients compared with the control group. The significantly enriched gene ontology biological process "anatomical structure morphogenesis" contained the highest number of genes in line with changes in structure that occur when the human heart remodels following AF development (ie, LA dilatation and interstitial fibrosis). We then focused the study on Pitx2 (paired-like homeodomain 2), being the most altered transcription factor in LA from AF patients and from which compelling evidence have indicated that its reduced expression can be considered as a marker for the disease. In addition, its expression was inversely correlated with LA size. We demonstrated that AF is associated with Pitx2 promoter hypermethylation both in humans and arrhythmic aging spontaneously hypertensive rats. Chronic administration of a DNA methylation inhibitor (ie, 5-Aza-2'-deoxycitidine) improved ECG arrhythmic profiles and superoxide dismutase activities and reduced fibrosis in the left ventricle of spontaneously hypertensive rats. Taken together, these data support the notion that AF is associated with epigenetic changes in LA and provide a proof-of-concept that hypomethylating agents have to be considered in the treatment of atrial arrhythmias.
Collapse
Affiliation(s)
| | - E Meugnier
- CarMeN Laboratory (UMR INSERM 1060-INRA 1397, INSA), Lyon-Sud Faculty of Medicine, University of Lyon, Pierre-Bénite, France
| | - C Romestaing
- LEHNA Laboratory, CNRS, UMR 5023, University of Lyon, Villeurbanne, France
| | - C Rey
- ProfilXpert, UNIV-US7 INSERM-UMS 3453 CNRS, Lyon, France
| | - E Morel
- Rhythmology Unit, Louis Pradel Cardiology Hospital, Hospices Civils de Lyon, Bron, France
| | - J Lachuer
- ProfilXpert, UNIV-US7 INSERM-UMS 3453 CNRS, Lyon, France
| | - N Gadot
- Plateform Anipath, Laënnec Faculty of Medecine, University of Lyon, Lyon, France
| | - A Scridon
- Physiology Department, University of Medicine and Pharmacy of Tîrgu Mures, Tîrgu Mures, Romania
| | - C Julien
- EA 4612 Neurocardiology unit, University of Lyon, Lyon, France
| | - F Tronc
- Pneumology Unit, Louis Pradel Cardiology Hospital, Hospices Civils de Lyon, Bron, France
| | - B Chapuis
- EA 4612 Neurocardiology unit, University of Lyon, Lyon, France
| | - C Valla
- Institut NeuroMyoGene (INMG), UMR CNRS 5310-INSERM U1217 / University of Lyon, Lyon, France
| | - A Janin
- Institut NeuroMyoGene (INMG), UMR CNRS 5310-INSERM U1217 / University of Lyon, Lyon, France
| | - L Pirola
- CarMeN Laboratory (UMR INSERM 1060-INRA 1397, INSA), Lyon-Sud Faculty of Medicine, University of Lyon, Pierre-Bénite, France
| | - A Méjat
- Institut NeuroMyoGene (INMG), UMR CNRS 5310-INSERM U1217 / University of Lyon, Lyon, France
| | - S Rome
- CarMeN Laboratory (UMR INSERM 1060-INRA 1397, INSA), Lyon-Sud Faculty of Medicine, University of Lyon, Pierre-Bénite, France
| | - Philippe Chevalier
- EA 4612 Neurocardiology unit, University of Lyon, Lyon, France; Rhythmology Unit, Louis Pradel Cardiology Hospital, Hospices Civils de Lyon, Bron, France.
| |
Collapse
|
34
|
Lecomte M, Couëdelo L, Meugnier E, Loizon E, Plaisancié P, Durand A, Géloën A, Joffre F, Vaysse C, Michalski MC, Laugerette F. Soybean polar lipids differently impact adipose tissue inflammation and the endotoxin transporters LBP and sCD14 in flaxseed vs. palm oil-rich diets. J Nutr Biochem 2017; 43:116-124. [PMID: 28284063 DOI: 10.1016/j.jnutbio.2017.02.004] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2016] [Revised: 01/06/2017] [Accepted: 02/08/2017] [Indexed: 01/09/2023]
Abstract
Obesity and type 2 diabetes are nutritional pathologies, characterized by a subclinical inflammatory state. Endotoxins are now well recognized as an important factor implicated in the onset and maintain of this inflammatory state during fat digestion in high-fat diet. As a preventive strategy, lipid formulation could be optimized to limit these phenomena, notably regarding fatty acid profile and PL emulsifier content. Little is known about soybean polar lipid (SPL) consumption associated to oils rich in saturated FA vs. anti-inflammatory omega-3 FA such as α-linolenic acid on inflammation and metabolic endotoxemia. We then investigated in mice the effect of different synthetic diets enriched with two different oils, palm oil or flaxseed oil and containing or devoid of SPL on adipose tissue inflammation and endotoxin receptors. In both groups containing SPL, adipose tissue (WAT) increased compared with groups devoid of SPL and an induction of MCP-1 and LBP was observed in WAT. However, only the high-fat diet in which flaxseed oil was associated with SPL resulted in both higher WAT inflammation and higher circulating sCD14 in plasma. In conclusion, we have demonstrated that LPS transporters LBP and sCD14 and adipose tissue inflammation can be modulated by SPL in high fat diets differing in oil composition. Notably high-flaxseed oil diet exerts a beneficial metabolic impact, however blunted by PL addition. Our study suggests that nutritional strategies can be envisaged by optimizing dietary lipid sources in manufactured products, including fats/oils and polar lipid emulsifiers, in order to limit the inflammatory impact of palatable foods.
Collapse
Affiliation(s)
- Manon Lecomte
- Univ-Lyon, CarMeN laboratory, INRA UMR1397, INSERM U1060, Université Claude Bernard Lyon 1, INSA-Lyon, IMBL, F-69621 Villeurbanne, France
| | - Leslie Couëdelo
- ITERG-ENMS, Université de Bordeaux, rue Léo Saignat, 33076 Bordeaux cedex, France
| | - Emmanuelle Meugnier
- INRA UMR1397, CarMeN laboratory, Univ-Lyon, INSERM U1060, Université Claude Bernard Lyon 1, F-69921 Oullins, France
| | - Emmanuelle Loizon
- INRA UMR1397, CarMeN laboratory, Univ-Lyon, INSERM U1060, Université Claude Bernard Lyon 1, F-69921 Oullins, France
| | - Pascale Plaisancié
- Univ-Lyon, CarMeN laboratory, INRA UMR1397, INSERM U1060, Université Claude Bernard Lyon 1, INSA-Lyon, IMBL, F-69621 Villeurbanne, France
| | - Annie Durand
- Univ-Lyon, CarMeN laboratory, INRA UMR1397, INSERM U1060, Université Claude Bernard Lyon 1, INSA-Lyon, IMBL, F-69621 Villeurbanne, France
| | - Alain Géloën
- Univ-Lyon, CarMeN laboratory, INRA UMR1397, INSERM U1060, Université Claude Bernard Lyon 1, INSA-Lyon, IMBL, F-69621 Villeurbanne, France
| | - Florent Joffre
- ITERG-ENMS, Université de Bordeaux, rue Léo Saignat, 33076 Bordeaux cedex, France
| | - Carole Vaysse
- ITERG-ENMS, Université de Bordeaux, rue Léo Saignat, 33076 Bordeaux cedex, France
| | - Marie-Caroline Michalski
- Univ-Lyon, CarMeN laboratory, INRA UMR1397, INSERM U1060, Université Claude Bernard Lyon 1, INSA-Lyon, IMBL, F-69621 Villeurbanne, France
| | - Fabienne Laugerette
- Univ-Lyon, CarMeN laboratory, INRA UMR1397, INSERM U1060, Université Claude Bernard Lyon 1, INSA-Lyon, IMBL, F-69621 Villeurbanne, France.
| |
Collapse
|
35
|
Donate Puertas R, Meugnier E, Romestaing C, Rey C, Morel E, Lachuer J, Gadot N, Julien C, Tronc F, Chapuis B, Pirola L, Méjat A, Rome S, Chevalier P. Atrial fibrillation is associated with hypermethylation in human left atrium and treatment with decitabine reduces atrial tachyarrhythmias in spontaneously hypertensive rats. Archives of Cardiovascular Diseases Supplements 2017. [DOI: 10.1016/s1878-6480(17)30493-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
36
|
Bessette C, Henry G, Sekkal S, Benoit B, Bruno J, Meugnier E, Ferrier L, Théodorou V, Léonil J, Plaisancié P. Oral administration of a casein matrix containing β-casofensin protects the intestinal barrier in two preclinical models of gut diseases. J Funct Foods 2016. [DOI: 10.1016/j.jff.2016.09.007] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
|
37
|
Seyssel K, Meugnier E, Lê KA, Durand C, Disse E, Blond E, Pays L, Nataf S, Brozek J, Vidal H, Tappy L, Laville M. Fructose overfeeding in first-degree relatives of type 2 diabetic patients impacts energy metabolism and mitochondrial functions in skeletal muscle. Mol Nutr Food Res 2016; 60:2691-2699. [PMID: 27468128 DOI: 10.1002/mnfr.201600407] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2016] [Revised: 07/06/2016] [Accepted: 07/20/2016] [Indexed: 12/17/2022]
Abstract
SCOPE The aim of the study was to assess the effects of a high-fructose diet (HFrD) on skeletal muscle transcriptomic response in healthy offspring of patients with type 2 diabetes, a subgroup of individuals prone to metabolic disorders. METHODS AND RESULTS Ten healthy normal weight first-degree relatives of type 2 diabetic patients were submitted to a HFrD (+3.5 g fructose/kg fat-free mass per day) during 7 days. A global transcriptomic analysis was performed on skeletal muscle biopsies combined with in vitro experiments using primary myotubes. Transcriptomic analysis highlighted profound effects on fatty acid oxidation and mitochondrial pathways supporting the whole-body metabolic shift with the preferential use of carbohydrates instead of lipids. Bioinformatics tools pointed out possible transcription factors orchestrating this genomic regulation, such as PPARα and NR4A2. In vitro experiments in human myotubes suggested an indirect action of fructose in skeletal muscle, which seemed to be independent from lactate, uric acid, or nitric oxide. CONCLUSION This study shows therefore that a large cluster of genes related to energy metabolism, mitochondrial function, and lipid oxidation was downregulated after 7 days of HFrD, thus supporting the concept that overconsumption of fructose-containing foods could contribute to metabolic deterioration in humans.
Collapse
Affiliation(s)
- Kevin Seyssel
- Lyon University, Oullins, France.,CarMeN Laboratory and CENS, Claude Bernard University, INSA Lyon, Oullins, France.,CRNH Rhône-Alpes, Centre Hospitalier Lyon-Sud, Pierre Bénite, France
| | - Emmanuelle Meugnier
- Lyon University, Oullins, France.,CarMeN Laboratory and CENS, Claude Bernard University, INSA Lyon, Oullins, France
| | - Kim-Anne Lê
- Department of Physiology, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland
| | - Christine Durand
- Lyon University, Oullins, France.,CarMeN Laboratory and CENS, Claude Bernard University, INSA Lyon, Oullins, France
| | - Emmanuel Disse
- Lyon University, Oullins, France.,CarMeN Laboratory and CENS, Claude Bernard University, INSA Lyon, Oullins, France.,CRNH Rhône-Alpes, Centre Hospitalier Lyon-Sud, Pierre Bénite, France
| | - Emilie Blond
- Lyon University, Oullins, France.,CarMeN Laboratory and CENS, Claude Bernard University, INSA Lyon, Oullins, France.,CRNH Rhône-Alpes, Centre Hospitalier Lyon-Sud, Pierre Bénite, France
| | - Laurent Pays
- Lyon University, Oullins, France.,CarMeN Laboratory and CENS, Claude Bernard University, INSA Lyon, Oullins, France.,Banque de Cellules et de Tissus, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France
| | - Serge Nataf
- Lyon University, Oullins, France.,CarMeN Laboratory and CENS, Claude Bernard University, INSA Lyon, Oullins, France.,Banque de Cellules et de Tissus, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France
| | | | - Hubert Vidal
- Lyon University, Oullins, France.,CarMeN Laboratory and CENS, Claude Bernard University, INSA Lyon, Oullins, France.,CRNH Rhône-Alpes, Centre Hospitalier Lyon-Sud, Pierre Bénite, France
| | - Luc Tappy
- Department of Physiology, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland
| | - Martine Laville
- Lyon University, Oullins, France.,CarMeN Laboratory and CENS, Claude Bernard University, INSA Lyon, Oullins, France.,CRNH Rhône-Alpes, Centre Hospitalier Lyon-Sud, Pierre Bénite, France
| |
Collapse
|
38
|
Jalabert A, Vial G, Guay C, Wiklander OPB, Nordin JZ, Aswad H, Forterre A, Meugnier E, Pesenti S, Regazzi R, Danty-Berger E, Ducreux S, Vidal H, El-Andaloussi S, Rieusset J, Rome S. Exosome-like vesicles released from lipid-induced insulin-resistant muscles modulate gene expression and proliferation of beta recipient cells in mice. Diabetologia 2016; 59:1049-58. [PMID: 26852333 DOI: 10.1007/s00125-016-3882-y] [Citation(s) in RCA: 115] [Impact Index Per Article: 14.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/11/2015] [Accepted: 01/15/2016] [Indexed: 12/14/2022]
Abstract
AIMS/HYPOTHESIS The crosstalk between skeletal muscle (SkM) and beta cells plays a role in diabetes aetiology. In this study, we have investigated whether SkM-released exosome-like vesicles (ELVs) can be taken up by pancreatic beta cells and can deliver functional cargoes. METHODS Mice were fed for 16 weeks with standard chow diet (SCD) or with standard diet enriched with 20% palmitate (HPD) and ELVs were purified from quadriceps muscle. Fluorescent ELVs from HPD or SCD quadriceps were injected i.v. or intramuscularly (i.m.) into mice to determine their biodistributions. Micro (mi)RNA quantification in ELVs was determined using quantitative real-time RT-PCR (qRT-PCR)-based TaqMan low-density arrays. Microarray analyses were performed to determine whether standard diet ELVs (SD-ELVs) and high palmitate diet ELVs (HPD-ELVs) induced specific transcriptional signatures in MIN6B1 cells. RESULTS In vivo, muscle ELVs were taken up by pancreas, 24 h post-injection. In vitro, both SD-ELVs and HPD-ELVs transferred proteins and miRNAs to MIN6B1 cells and modulated gene expressions whereas only HPD-ELVs induced proliferation of MIN6B1 cells and isolated islets. Bioinformatic analyses suggested that transferred HPD-ELV miRNAs may participate in these effects. To validate this, we demonstrated that miR-16, which is overexpressed in HPD-ELVs, was transferred to MIN6B1 cells and regulated Ptch1, involved in pancreas development. In vivo, islets from HPD mice showed increased size and altered expression of genes involved in development, including Ptch1, suggesting that the effect of palm oil on islet size in vivo was reproduced in vitro by treating beta cells with HPD-ELVs. CONCLUSIONS/INTERPRETATION Our data suggest that muscle ELVs might have an endocrine effect and could participate in adaptations in beta cell mass during insulin resistance.
Collapse
Affiliation(s)
- Audrey Jalabert
- CarMeN laboratory (Inserm 1060, INRA 1397, INSA), University of Lyon, Faculté de Médecine Lyon-Sud, Chemin du Grand Revoyet, 69600, Oullins, France
| | - Guillaume Vial
- CarMeN laboratory (Inserm 1060, INRA 1397, INSA), University of Lyon, Faculté de Médecine Lyon-Sud, Chemin du Grand Revoyet, 69600, Oullins, France
| | - Claudiane Guay
- Department of Fundamental Neurosciences, University of Lausanne, Lausanne, Switzerland
| | - Oscar P B Wiklander
- Department of Laboratory Medicine, Clinical Research Center, Karolinska Institutet, Karolinska University Hospital Huddinge, Huddinge, Sweden
| | - Joel Z Nordin
- Department of Laboratory Medicine, Clinical Research Center, Karolinska Institutet, Karolinska University Hospital Huddinge, Huddinge, Sweden
| | - Hala Aswad
- CarMeN laboratory (Inserm 1060, INRA 1397, INSA), University of Lyon, Faculté de Médecine Lyon-Sud, Chemin du Grand Revoyet, 69600, Oullins, France
| | - Alexis Forterre
- CarMeN laboratory (Inserm 1060, INRA 1397, INSA), University of Lyon, Faculté de Médecine Lyon-Sud, Chemin du Grand Revoyet, 69600, Oullins, France
| | - Emmanuelle Meugnier
- CarMeN laboratory (Inserm 1060, INRA 1397, INSA), University of Lyon, Faculté de Médecine Lyon-Sud, Chemin du Grand Revoyet, 69600, Oullins, France
| | - Sandra Pesenti
- CarMeN laboratory (Inserm 1060, INRA 1397, INSA), University of Lyon, Faculté de Médecine Lyon-Sud, Chemin du Grand Revoyet, 69600, Oullins, France
| | - Romano Regazzi
- Department of Fundamental Neurosciences, University of Lausanne, Lausanne, Switzerland
| | - Emmanuelle Danty-Berger
- CarMeN laboratory (Inserm 1060, INRA 1397, INSA), University of Lyon, Faculté de Médecine Lyon-Sud, Chemin du Grand Revoyet, 69600, Oullins, France
| | - Sylvie Ducreux
- CarMeN laboratory (Inserm 1060, INRA 1397, INSA), University of Lyon, Faculté de Médecine Lyon-Sud, Chemin du Grand Revoyet, 69600, Oullins, France
| | - Hubert Vidal
- CarMeN laboratory (Inserm 1060, INRA 1397, INSA), University of Lyon, Faculté de Médecine Lyon-Sud, Chemin du Grand Revoyet, 69600, Oullins, France
| | - Samir El-Andaloussi
- Department of Laboratory Medicine, Clinical Research Center, Karolinska Institutet, Karolinska University Hospital Huddinge, Huddinge, Sweden
- Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK
| | - Jennifer Rieusset
- CarMeN laboratory (Inserm 1060, INRA 1397, INSA), University of Lyon, Faculté de Médecine Lyon-Sud, Chemin du Grand Revoyet, 69600, Oullins, France
| | - Sophie Rome
- CarMeN laboratory (Inserm 1060, INRA 1397, INSA), University of Lyon, Faculté de Médecine Lyon-Sud, Chemin du Grand Revoyet, 69600, Oullins, France.
| |
Collapse
|
39
|
Lecomte M, Couëdelo L, Meugnier E, Plaisancié P, Létisse M, Benoit B, Gabert L, Penhoat A, Durand A, Pineau G, Joffre F, Géloën A, Vaysse C, Laugerette F, Michalski MC. Dietary emulsifiers from milk and soybean differently impact adiposity and inflammation in association with modulation of colonic goblet cells in high-fat fed mice. Mol Nutr Food Res 2016; 60:609-20. [PMID: 26592505 DOI: 10.1002/mnfr.201500703] [Citation(s) in RCA: 63] [Impact Index Per Article: 7.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2015] [Revised: 11/04/2015] [Accepted: 11/09/2015] [Indexed: 12/12/2022]
Abstract
SCOPE Enhanced adiposity and metabolic inflammation are major features of obesity that could be impacted by dietary emulsifiers. We investigated in high-fat fed mice the effects of using a new polar lipid (PL) emulsifier from milk (MPL) instead of soybean lecithin (soybean PL [SPL]) on adipose tissue and intestinal mucosa function. METHODS AND RESULTS Four groups of C57BL6 mice received for 8 wks a low-fat (LF) diet or a high-fat diet devoid of PLs or an high-fat diet including MPL (high-fat-MPL) or SPL (high-fat-SPL). Compared with high-fat diet, high-fat-SPL diet increased white adipose tissue (WAT) mass (p < 0.05), with larger adipocytes (p < 0.05) and increased expression of tumor necrosis factor alpha, monochemoattractant protein-1, LPS-binding protein, and leptin (p < 0.05). This was not observed with high-fat-MPL diet despite similar dietary intakes and increased expression of fatty acid transport protein 4 and microsomal TG transfer protein, involved in lipid absorption, in upper intestine (p < 0.05). High-fat-MPL mice had a lower expression in WAT of cluster of differentiation 68, marker of macrophage infiltration, versus high-fat and high-fat-SPL mice (p < 0.05), and more goblet cells in the colon (p < 0.05). CONCLUSIONS Unlike SPL, MPL in the high-fat diet did not induce WAT hypertrophy and inflammation but increased colonic goblet cells. This supports further clinical exploration of different sources of dietary emulsifiers in the frame of obesity outbreak.
Collapse
Affiliation(s)
- Manon Lecomte
- INRA, UMR1397, INSERM U1060, CarMeN Laboratory, INSA-Lyon, IMBL, Université Lyon 1, Villeurbanne, France
| | | | | | - Pascale Plaisancié
- INRA, UMR1397, INSERM U1060, CarMeN Laboratory, INSA-Lyon, IMBL, Université Lyon 1, Villeurbanne, France
| | - Marion Létisse
- INRA, UMR1397, INSERM U1060, CarMeN Laboratory, INSA-Lyon, IMBL, Université Lyon 1, Villeurbanne, France
| | - Bérengère Benoit
- INRA, UMR1397, INSERM U1060, CarMeN Laboratory, INSA-Lyon, IMBL, Université Lyon 1, Villeurbanne, France
| | - Laure Gabert
- INSERM U1060, INRA UMR1397, CarMeN Laboratory, Oullins, France
- Centre de Recherche en Nutrition Humaine Rhône-Alpes (CRNH-RA) and Centre Européen pour la Nutrition et la Santé (CENS), Pierre-Bénite, France
| | - Armelle Penhoat
- INRA, UMR1397, INSERM U1060, CarMeN Laboratory, INSA-Lyon, IMBL, Université Lyon 1, Villeurbanne, France
| | - Annie Durand
- INRA, UMR1397, INSERM U1060, CarMeN Laboratory, INSA-Lyon, IMBL, Université Lyon 1, Villeurbanne, France
| | - Gaëlle Pineau
- INRA, UMR1397, INSERM U1060, CarMeN Laboratory, INSA-Lyon, IMBL, Université Lyon 1, Villeurbanne, France
| | | | - Alain Géloën
- INRA, UMR1397, INSERM U1060, CarMeN Laboratory, INSA-Lyon, IMBL, Université Lyon 1, Villeurbanne, France
| | | | - Fabienne Laugerette
- INRA, UMR1397, INSERM U1060, CarMeN Laboratory, INSA-Lyon, IMBL, Université Lyon 1, Villeurbanne, France
| | - Marie-Caroline Michalski
- INRA, UMR1397, INSERM U1060, CarMeN Laboratory, INSA-Lyon, IMBL, Université Lyon 1, Villeurbanne, France
- Centre de Recherche en Nutrition Humaine Rhône-Alpes (CRNH-RA) and Centre Européen pour la Nutrition et la Santé (CENS), Pierre-Bénite, France
| |
Collapse
|
40
|
Marchand L, Jalabert A, Meugnier E, Van den Hende K, Fabien N, Nicolino M, Madec AM, Thivolet C, Rome S. miRNA-375 a Sensor of Glucotoxicity Is Altered in the Serum of Children with Newly Diagnosed Type 1 Diabetes. J Diabetes Res 2016; 2016:1869082. [PMID: 27314045 PMCID: PMC4895032 DOI: 10.1155/2016/1869082] [Citation(s) in RCA: 54] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/18/2016] [Revised: 03/11/2016] [Accepted: 04/19/2016] [Indexed: 12/18/2022] Open
Abstract
Background. The use of miRNAs as biomarkers for Type 1 Diabetes (T1D) risk is attractive as T1D is usually diagnosed in front of acute symptoms. As miR-375 is highly expressed in the endocrine pancreas, we postulated that its circulating level might reflect beta cell alterations and might be altered in the blood of T1D patients recently diagnosed. Methods. Sera were obtained from 22 T1D children at onset of the disease, before subcutaneous insulin treatment, and from 10 nondiabetic pediatric controls. MiR-375 seric level was quantified by stem-loop RT-PCR-based assay. MiRNAs regulations in isolated human islets in response to high glucose concentrations were determined by TaqMan Low-Density Array. Results. The abundance of miR-375, among the 410 miRNAs detected in human islets, mirrored its well-established role in rodent islet biology. Upregulated miRNAs targeted genes involved in islet homeostasis and regulation of beta cell mass. Downregulated miRNAs, including miR-375, were involved in pancreas secretion and protein turnover. Seric level of miR-375 was lower in T1D children versus age-matched controls, without any correlations with HbA1c, glycaemia, and number of autoantibodies. Conclusion. Altered circulating level of miR-375 at onset of T1D might be a general biomarker of metabolic alterations and inflammation associated with the disease.
Collapse
Affiliation(s)
- Lucien Marchand
- CarMeN Laboratory (INSERM 1060, INRA 1362, INSA), Lyon-Sud Faculty of Medicine, University of Lyon, Chemin du Grand Revoyet, 69600 Oullins, France
- Hospices Civils de Lyon, Lyon-Sud Hospital, Department of Diabetology and Endocrinology, 69495 Pierre-Bénite, France
| | - Audrey Jalabert
- CarMeN Laboratory (INSERM 1060, INRA 1362, INSA), Lyon-Sud Faculty of Medicine, University of Lyon, Chemin du Grand Revoyet, 69600 Oullins, France
| | - Emmanuelle Meugnier
- CarMeN Laboratory (INSERM 1060, INRA 1362, INSA), Lyon-Sud Faculty of Medicine, University of Lyon, Chemin du Grand Revoyet, 69600 Oullins, France
| | - Kathleen Van den Hende
- Hospices Civils de Lyon, Department of Pediatric Endocrinology, Femme-Mère-Enfant Hospital, 69500 Bron, France
| | - Nicole Fabien
- Hospices Civils de Lyon, INSERM U851, Lyon-Sud Hospital, Department of Immunology, 69495 Pierre-Bénite, France
| | - Marc Nicolino
- CarMeN Laboratory (INSERM 1060, INRA 1362, INSA), Lyon-Sud Faculty of Medicine, University of Lyon, Chemin du Grand Revoyet, 69600 Oullins, France
- Hospices Civils de Lyon, Department of Pediatric Endocrinology, Femme-Mère-Enfant Hospital, 69500 Bron, France
| | - Anne-Marie Madec
- CarMeN Laboratory (INSERM 1060, INRA 1362, INSA), Lyon-Sud Faculty of Medicine, University of Lyon, Chemin du Grand Revoyet, 69600 Oullins, France
| | - Charles Thivolet
- CarMeN Laboratory (INSERM 1060, INRA 1362, INSA), Lyon-Sud Faculty of Medicine, University of Lyon, Chemin du Grand Revoyet, 69600 Oullins, France
- Hospices Civils de Lyon, Lyon-Sud Hospital, Department of Diabetology and Endocrinology, 69495 Pierre-Bénite, France
| | - Sophie Rome
- CarMeN Laboratory (INSERM 1060, INRA 1362, INSA), Lyon-Sud Faculty of Medicine, University of Lyon, Chemin du Grand Revoyet, 69600 Oullins, France
- *Sophie Rome:
| |
Collapse
|
41
|
Vors C, Pineau G, Drai J, Meugnier E, Pesenti S, Laville M, Laugerette F, Malpuech-Brugère C, Vidal H, Michalski MC. Postprandial Endotoxemia Linked With Chylomicrons and Lipopolysaccharides Handling in Obese Versus Lean Men: A Lipid Dose-Effect Trial. J Clin Endocrinol Metab 2015; 100:3427-35. [PMID: 26151336 DOI: 10.1210/jc.2015-2518] [Citation(s) in RCA: 97] [Impact Index Per Article: 10.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
CONTEXT Postprandial endotoxemia is a metabolic risk factor, which has been shown to originate from the intestinal absorption of gut lipopolysaccharides (LPS) using nonphysiological high-fat tests. OBJECTIVE This study aimed to determine whether different realistic fat amounts can modulate postprandial dynamics and handling of LPS by varying postprandial lipidemia in humans of different body mass indices. DESIGN, SETTING, AND PARTICIPANTS In a randomized, controlled, cross-over study in nutrition research center, eight normal-weight (NW) and eight obese age-matched men, without diabetes nor dyslipidemia, ingested breakfasts containing 10 vs 40 g fat. Blood samples, leukocytes, and chylomicron-rich fractions were obtained during 8 h. Plasma and chylomicron-endotoxemia, plasma LPS transporters (LBP, sCD14) and IL-6, nuclear factor κB (NF-κB) translocation, and IL-6 gene expression of immune cells were measured. MAIN OUTCOME The postprandial fatty acid handling after ingesting 40 g fat was previously published as primary outcome. The secondary outcomes were inflammatory ones including postprandial endotoxemia, LPS handling, and plasma markers of inflammation after ingesting 10 or 40 g fat. RESULTS Chylomicronemia increased in all subjects according to ingested fat amount (P < .01), but only obese had higher postprandial endotoxemia after 40 g (P < .05). Obese subject chylomicrons were more enriched with LPS compared with NW (PBMI < .01). We observed neither NF-κB translocation, nor variation of IL-6 expression in leukocytes. In both groups, fat amount did not modify postprandial response of plasma IL-6. However, the area under the curve (AUC) of IL-6 in obese was higher than in NW (P < .05) parallel to higher fasting LPS-binding protein (LBP; P < .05). AUC of IL-6 was correlated with LBP (P < .01). CONCLUSION Postprandial endotoxemia is modulated by ingested fat amount in obese men. LPS handling in plasma through chylomicrons and LBP seems critical in driving the acute inflammatory response. The pathophysiological importance of repeated postprandial endotoxemia excursions and their contribution to a vicious cycle of LBP-driven low-grade inflammation deserve further investigation in the nutritional management of cardio-metabolic risk prevention.
Collapse
Affiliation(s)
- Cécile Vors
- Université de Lyon (C.V., E.M., M.L., F.L., H.V., M.-C.M.), Institut National de la Recherche Agronomique, CarMeN Laboratory, Univ Lyon-1, Oullins, 69600 France; Institut National de la Santé Et de la Recherche Médicale Unité 1060 (S.P., H.V.), CarMeN Laboratory, Oullins, 69600 France; Centre de Recherche en Nutrition Humaine Rhône-Alpes and Centre Européen pour la Nutrition et la Santé (C.V., M.L., M.-C.M.), Pierre-Bénite, 69310 France; Institut National de la Recherche Agronomique Unité Mixte de Recherche 1397 (G.P., F.L., M.-C.M.), CarMeN Laboratory, Villeurbanne, 69100 France; Institut National des Sciences Appliquées-Lyon, Institut Multidisciplinaire de Biochimie des Lipides (G.P.), Villeurbanne, France; Laboratoire de Biochimie (J.D.), Centre Hospitalier Lyon Sud, Pierre-Bénite, France; Université d'Auvergne (C.M.-B.), Unité de Nutrition Humaine, Clermont-Ferrand, 63000 France; and Institut National de la Recherche Agronomique Unité Mixte de Recherche 1019 (C.M.-B.), Unité de Nutrition Humaine, Clermont-Ferrand, 63000 France
| | - Gaëlle Pineau
- Université de Lyon (C.V., E.M., M.L., F.L., H.V., M.-C.M.), Institut National de la Recherche Agronomique, CarMeN Laboratory, Univ Lyon-1, Oullins, 69600 France; Institut National de la Santé Et de la Recherche Médicale Unité 1060 (S.P., H.V.), CarMeN Laboratory, Oullins, 69600 France; Centre de Recherche en Nutrition Humaine Rhône-Alpes and Centre Européen pour la Nutrition et la Santé (C.V., M.L., M.-C.M.), Pierre-Bénite, 69310 France; Institut National de la Recherche Agronomique Unité Mixte de Recherche 1397 (G.P., F.L., M.-C.M.), CarMeN Laboratory, Villeurbanne, 69100 France; Institut National des Sciences Appliquées-Lyon, Institut Multidisciplinaire de Biochimie des Lipides (G.P.), Villeurbanne, France; Laboratoire de Biochimie (J.D.), Centre Hospitalier Lyon Sud, Pierre-Bénite, France; Université d'Auvergne (C.M.-B.), Unité de Nutrition Humaine, Clermont-Ferrand, 63000 France; and Institut National de la Recherche Agronomique Unité Mixte de Recherche 1019 (C.M.-B.), Unité de Nutrition Humaine, Clermont-Ferrand, 63000 France
| | - Jocelyne Drai
- Université de Lyon (C.V., E.M., M.L., F.L., H.V., M.-C.M.), Institut National de la Recherche Agronomique, CarMeN Laboratory, Univ Lyon-1, Oullins, 69600 France; Institut National de la Santé Et de la Recherche Médicale Unité 1060 (S.P., H.V.), CarMeN Laboratory, Oullins, 69600 France; Centre de Recherche en Nutrition Humaine Rhône-Alpes and Centre Européen pour la Nutrition et la Santé (C.V., M.L., M.-C.M.), Pierre-Bénite, 69310 France; Institut National de la Recherche Agronomique Unité Mixte de Recherche 1397 (G.P., F.L., M.-C.M.), CarMeN Laboratory, Villeurbanne, 69100 France; Institut National des Sciences Appliquées-Lyon, Institut Multidisciplinaire de Biochimie des Lipides (G.P.), Villeurbanne, France; Laboratoire de Biochimie (J.D.), Centre Hospitalier Lyon Sud, Pierre-Bénite, France; Université d'Auvergne (C.M.-B.), Unité de Nutrition Humaine, Clermont-Ferrand, 63000 France; and Institut National de la Recherche Agronomique Unité Mixte de Recherche 1019 (C.M.-B.), Unité de Nutrition Humaine, Clermont-Ferrand, 63000 France
| | - Emmanuelle Meugnier
- Université de Lyon (C.V., E.M., M.L., F.L., H.V., M.-C.M.), Institut National de la Recherche Agronomique, CarMeN Laboratory, Univ Lyon-1, Oullins, 69600 France; Institut National de la Santé Et de la Recherche Médicale Unité 1060 (S.P., H.V.), CarMeN Laboratory, Oullins, 69600 France; Centre de Recherche en Nutrition Humaine Rhône-Alpes and Centre Européen pour la Nutrition et la Santé (C.V., M.L., M.-C.M.), Pierre-Bénite, 69310 France; Institut National de la Recherche Agronomique Unité Mixte de Recherche 1397 (G.P., F.L., M.-C.M.), CarMeN Laboratory, Villeurbanne, 69100 France; Institut National des Sciences Appliquées-Lyon, Institut Multidisciplinaire de Biochimie des Lipides (G.P.), Villeurbanne, France; Laboratoire de Biochimie (J.D.), Centre Hospitalier Lyon Sud, Pierre-Bénite, France; Université d'Auvergne (C.M.-B.), Unité de Nutrition Humaine, Clermont-Ferrand, 63000 France; and Institut National de la Recherche Agronomique Unité Mixte de Recherche 1019 (C.M.-B.), Unité de Nutrition Humaine, Clermont-Ferrand, 63000 France
| | - Sandra Pesenti
- Université de Lyon (C.V., E.M., M.L., F.L., H.V., M.-C.M.), Institut National de la Recherche Agronomique, CarMeN Laboratory, Univ Lyon-1, Oullins, 69600 France; Institut National de la Santé Et de la Recherche Médicale Unité 1060 (S.P., H.V.), CarMeN Laboratory, Oullins, 69600 France; Centre de Recherche en Nutrition Humaine Rhône-Alpes and Centre Européen pour la Nutrition et la Santé (C.V., M.L., M.-C.M.), Pierre-Bénite, 69310 France; Institut National de la Recherche Agronomique Unité Mixte de Recherche 1397 (G.P., F.L., M.-C.M.), CarMeN Laboratory, Villeurbanne, 69100 France; Institut National des Sciences Appliquées-Lyon, Institut Multidisciplinaire de Biochimie des Lipides (G.P.), Villeurbanne, France; Laboratoire de Biochimie (J.D.), Centre Hospitalier Lyon Sud, Pierre-Bénite, France; Université d'Auvergne (C.M.-B.), Unité de Nutrition Humaine, Clermont-Ferrand, 63000 France; and Institut National de la Recherche Agronomique Unité Mixte de Recherche 1019 (C.M.-B.), Unité de Nutrition Humaine, Clermont-Ferrand, 63000 France
| | - Martine Laville
- Université de Lyon (C.V., E.M., M.L., F.L., H.V., M.-C.M.), Institut National de la Recherche Agronomique, CarMeN Laboratory, Univ Lyon-1, Oullins, 69600 France; Institut National de la Santé Et de la Recherche Médicale Unité 1060 (S.P., H.V.), CarMeN Laboratory, Oullins, 69600 France; Centre de Recherche en Nutrition Humaine Rhône-Alpes and Centre Européen pour la Nutrition et la Santé (C.V., M.L., M.-C.M.), Pierre-Bénite, 69310 France; Institut National de la Recherche Agronomique Unité Mixte de Recherche 1397 (G.P., F.L., M.-C.M.), CarMeN Laboratory, Villeurbanne, 69100 France; Institut National des Sciences Appliquées-Lyon, Institut Multidisciplinaire de Biochimie des Lipides (G.P.), Villeurbanne, France; Laboratoire de Biochimie (J.D.), Centre Hospitalier Lyon Sud, Pierre-Bénite, France; Université d'Auvergne (C.M.-B.), Unité de Nutrition Humaine, Clermont-Ferrand, 63000 France; and Institut National de la Recherche Agronomique Unité Mixte de Recherche 1019 (C.M.-B.), Unité de Nutrition Humaine, Clermont-Ferrand, 63000 France
| | - Fabienne Laugerette
- Université de Lyon (C.V., E.M., M.L., F.L., H.V., M.-C.M.), Institut National de la Recherche Agronomique, CarMeN Laboratory, Univ Lyon-1, Oullins, 69600 France; Institut National de la Santé Et de la Recherche Médicale Unité 1060 (S.P., H.V.), CarMeN Laboratory, Oullins, 69600 France; Centre de Recherche en Nutrition Humaine Rhône-Alpes and Centre Européen pour la Nutrition et la Santé (C.V., M.L., M.-C.M.), Pierre-Bénite, 69310 France; Institut National de la Recherche Agronomique Unité Mixte de Recherche 1397 (G.P., F.L., M.-C.M.), CarMeN Laboratory, Villeurbanne, 69100 France; Institut National des Sciences Appliquées-Lyon, Institut Multidisciplinaire de Biochimie des Lipides (G.P.), Villeurbanne, France; Laboratoire de Biochimie (J.D.), Centre Hospitalier Lyon Sud, Pierre-Bénite, France; Université d'Auvergne (C.M.-B.), Unité de Nutrition Humaine, Clermont-Ferrand, 63000 France; and Institut National de la Recherche Agronomique Unité Mixte de Recherche 1019 (C.M.-B.), Unité de Nutrition Humaine, Clermont-Ferrand, 63000 France
| | - Corinne Malpuech-Brugère
- Université de Lyon (C.V., E.M., M.L., F.L., H.V., M.-C.M.), Institut National de la Recherche Agronomique, CarMeN Laboratory, Univ Lyon-1, Oullins, 69600 France; Institut National de la Santé Et de la Recherche Médicale Unité 1060 (S.P., H.V.), CarMeN Laboratory, Oullins, 69600 France; Centre de Recherche en Nutrition Humaine Rhône-Alpes and Centre Européen pour la Nutrition et la Santé (C.V., M.L., M.-C.M.), Pierre-Bénite, 69310 France; Institut National de la Recherche Agronomique Unité Mixte de Recherche 1397 (G.P., F.L., M.-C.M.), CarMeN Laboratory, Villeurbanne, 69100 France; Institut National des Sciences Appliquées-Lyon, Institut Multidisciplinaire de Biochimie des Lipides (G.P.), Villeurbanne, France; Laboratoire de Biochimie (J.D.), Centre Hospitalier Lyon Sud, Pierre-Bénite, France; Université d'Auvergne (C.M.-B.), Unité de Nutrition Humaine, Clermont-Ferrand, 63000 France; and Institut National de la Recherche Agronomique Unité Mixte de Recherche 1019 (C.M.-B.), Unité de Nutrition Humaine, Clermont-Ferrand, 63000 France
| | - Hubert Vidal
- Université de Lyon (C.V., E.M., M.L., F.L., H.V., M.-C.M.), Institut National de la Recherche Agronomique, CarMeN Laboratory, Univ Lyon-1, Oullins, 69600 France; Institut National de la Santé Et de la Recherche Médicale Unité 1060 (S.P., H.V.), CarMeN Laboratory, Oullins, 69600 France; Centre de Recherche en Nutrition Humaine Rhône-Alpes and Centre Européen pour la Nutrition et la Santé (C.V., M.L., M.-C.M.), Pierre-Bénite, 69310 France; Institut National de la Recherche Agronomique Unité Mixte de Recherche 1397 (G.P., F.L., M.-C.M.), CarMeN Laboratory, Villeurbanne, 69100 France; Institut National des Sciences Appliquées-Lyon, Institut Multidisciplinaire de Biochimie des Lipides (G.P.), Villeurbanne, France; Laboratoire de Biochimie (J.D.), Centre Hospitalier Lyon Sud, Pierre-Bénite, France; Université d'Auvergne (C.M.-B.), Unité de Nutrition Humaine, Clermont-Ferrand, 63000 France; and Institut National de la Recherche Agronomique Unité Mixte de Recherche 1019 (C.M.-B.), Unité de Nutrition Humaine, Clermont-Ferrand, 63000 France
| | - Marie-Caroline Michalski
- Université de Lyon (C.V., E.M., M.L., F.L., H.V., M.-C.M.), Institut National de la Recherche Agronomique, CarMeN Laboratory, Univ Lyon-1, Oullins, 69600 France; Institut National de la Santé Et de la Recherche Médicale Unité 1060 (S.P., H.V.), CarMeN Laboratory, Oullins, 69600 France; Centre de Recherche en Nutrition Humaine Rhône-Alpes and Centre Européen pour la Nutrition et la Santé (C.V., M.L., M.-C.M.), Pierre-Bénite, 69310 France; Institut National de la Recherche Agronomique Unité Mixte de Recherche 1397 (G.P., F.L., M.-C.M.), CarMeN Laboratory, Villeurbanne, 69100 France; Institut National des Sciences Appliquées-Lyon, Institut Multidisciplinaire de Biochimie des Lipides (G.P.), Villeurbanne, France; Laboratoire de Biochimie (J.D.), Centre Hospitalier Lyon Sud, Pierre-Bénite, France; Université d'Auvergne (C.M.-B.), Unité de Nutrition Humaine, Clermont-Ferrand, 63000 France; and Institut National de la Recherche Agronomique Unité Mixte de Recherche 1019 (C.M.-B.), Unité de Nutrition Humaine, Clermont-Ferrand, 63000 France
| |
Collapse
|
42
|
Lecomte M, Bourlieu C, Meugnier E, Penhoat A, Cheillan D, Pineau G, Loizon E, Trauchessec M, Claude M, Ménard O, Géloën A, Laugerette F, Michalski MC. Milk Polar Lipids Affect In Vitro Digestive Lipolysis and Postprandial Lipid Metabolism in Mice. J Nutr 2015; 145:1770-7. [PMID: 26136586 DOI: 10.3945/jn.115.212068] [Citation(s) in RCA: 60] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2015] [Accepted: 06/03/2015] [Indexed: 12/17/2022] Open
Abstract
BACKGROUND Polar lipid (PL) emulsifiers such as milk PLs (MPLs) may affect digestion and subsequent lipid metabolism, but focused studies on postprandial lipemia are lacking. OBJECTIVE We evaluated the impact of MPLs on postprandial lipemia in mice and on lipid digestion in vitro. METHODS Female Swiss mice were gavaged with 150 μL of an oil-in-water emulsion stabilized with 5.7 mg of either MPLs or soybean PLs (SPLs) and killed after 1, 2, or 4 h. Plasma lipids were quantified and in the small intestine, gene expression was analyzed by reverse transcriptase-quantitative polymerase chain reaction. Emulsions were lipolyzed in vitro using a static human digestion model; triglyceride (TG) disappearance was followed by thin-layer chromatography. RESULTS In mice, after 1 h, plasma TGs tended to be higher in the MPL group than in the SPL group (141 μg/mL vs. 90 μg/mL; P = 0.07) and nonesterified fatty acids (NEFAs) were significantly higher (64 μg/mL vs. 44 μg/mL; P < 0.05). The opposite was observed after 4 h with lower TGs (21 μg/mL vs. 35 μg/mL; P < 0.01) and NEFAs (20 μg/mL vs. 32 μg/mL; P < 0.01) in the MPL group compared with the SPL group. This was associated at 4 h with a lower gene expression of apolipoprotein B (Apob) and Secretion Associated, Ras related GTPase 1 gene homolog B (Sar1b), in the duodenum of MPL mice compared with SPL mice (P < 0.05). In vitro, during the intestinal phase, TGs were hydrolyzed more in the MPL emulsion than in the SPL emulsion (decremental AUCs were 1750%/min vs. 180%/min; P < 0.01). MPLs enhance lipid intestinal hydrolysis and promote more rapid intestinal lipid absorption and sharper kinetics of lipemia. CONCLUSIONS Postprandial lipemia in mice can be modulated by emulsifying with MPLs compared with SPLs, partly through differences in chylomicron assembly, and TG hydrolysis rate as observed in vitro. MPLs may thereby contribute to the long-term regulation of lipid metabolism.
Collapse
Affiliation(s)
- Manon Lecomte
- UMR 1397 National Institute for Agricultural Research (INRA), Lyon 1 University, U1060 National Institute of Health and Medical Research (INSERM), National Institute of Applied Science of Lyon, INSA-Lyon, Institute for Multidisciplinary Biochemistry of Lipids, Cardiovascular, Metabolism, Diabetologia and Nutrition Laboratory, Villeurbanne, France
| | - Claire Bourlieu
- UMR 1253 National Institute for Agricultural Research (INRA), Science & Technology of Milk and Egg, Rennes, France; Agrocampus Ouest, Science & Technology of Milk and Egg, Rennes, France
| | - Emmanuelle Meugnier
- U1060 National Institute of Health and Medical Research (INSERM), UMR 1397 National Institute for Agricultural Research (INRA), Cardiovascular, Metabolism, Diabetologia and Nutrition Laboratory, Oullins, France; and
| | - Armelle Penhoat
- UMR 1397 National Institute for Agricultural Research (INRA), Lyon 1 University, U1060 National Institute of Health and Medical Research (INSERM), National Institute of Applied Science of Lyon, INSA-Lyon, Institute for Multidisciplinary Biochemistry of Lipids, Cardiovascular, Metabolism, Diabetologia and Nutrition Laboratory, Villeurbanne, France
| | - David Cheillan
- UMR 1397 National Institute for Agricultural Research (INRA), Lyon 1 University, U1060 National Institute of Health and Medical Research (INSERM), National Institute of Applied Science of Lyon, INSA-Lyon, Institute for Multidisciplinary Biochemistry of Lipids, Cardiovascular, Metabolism, Diabetologia and Nutrition Laboratory, Villeurbanne, France; Hereditary Metabolic Diseases Department, East Medical Group, Lyon Civil Hospitals, Lyon, France
| | - Gaëlle Pineau
- UMR 1397 National Institute for Agricultural Research (INRA), Lyon 1 University, U1060 National Institute of Health and Medical Research (INSERM), National Institute of Applied Science of Lyon, INSA-Lyon, Institute for Multidisciplinary Biochemistry of Lipids, Cardiovascular, Metabolism, Diabetologia and Nutrition Laboratory, Villeurbanne, France
| | - Emmanuelle Loizon
- U1060 National Institute of Health and Medical Research (INSERM), UMR 1397 National Institute for Agricultural Research (INRA), Cardiovascular, Metabolism, Diabetologia and Nutrition Laboratory, Oullins, France; and
| | - Michèle Trauchessec
- Hereditary Metabolic Diseases Department, East Medical Group, Lyon Civil Hospitals, Lyon, France
| | - Mathilde Claude
- UMR 1253 National Institute for Agricultural Research (INRA), Science & Technology of Milk and Egg, Rennes, France; Agrocampus Ouest, Science & Technology of Milk and Egg, Rennes, France
| | - Olivia Ménard
- UMR 1253 National Institute for Agricultural Research (INRA), Science & Technology of Milk and Egg, Rennes, France; Agrocampus Ouest, Science & Technology of Milk and Egg, Rennes, France
| | - Alain Géloën
- UMR 1397 National Institute for Agricultural Research (INRA), Lyon 1 University, U1060 National Institute of Health and Medical Research (INSERM), National Institute of Applied Science of Lyon, INSA-Lyon, Institute for Multidisciplinary Biochemistry of Lipids, Cardiovascular, Metabolism, Diabetologia and Nutrition Laboratory, Villeurbanne, France
| | - Fabienne Laugerette
- UMR 1397 National Institute for Agricultural Research (INRA), Lyon 1 University, U1060 National Institute of Health and Medical Research (INSERM), National Institute of Applied Science of Lyon, INSA-Lyon, Institute for Multidisciplinary Biochemistry of Lipids, Cardiovascular, Metabolism, Diabetologia and Nutrition Laboratory, Villeurbanne, France
| | - Marie-Caroline Michalski
- UMR 1397 National Institute for Agricultural Research (INRA), Lyon 1 University, U1060 National Institute of Health and Medical Research (INSERM), National Institute of Applied Science of Lyon, INSA-Lyon, Institute for Multidisciplinary Biochemistry of Lipids, Cardiovascular, Metabolism, Diabetologia and Nutrition Laboratory, Villeurbanne, France;
| |
Collapse
|
43
|
Vial G, Chauvin MA, Bendridi N, Durand A, Meugnier E, Madec AM, Bernoud-Hubac N, Pais de Barros JP, Fontaine É, Acquaviva C, Hallakou-Bozec S, Bolze S, Vidal H, Rieusset J. Imeglimin normalizes glucose tolerance and insulin sensitivity and improves mitochondrial function in liver of a high-fat, high-sucrose diet mice model. Diabetes 2015; 64:2254-64. [PMID: 25552598 DOI: 10.2337/db14-1220] [Citation(s) in RCA: 101] [Impact Index Per Article: 11.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/06/2014] [Accepted: 12/20/2014] [Indexed: 12/13/2022]
Abstract
Imeglimin is the first in a new class of oral glucose-lowering agents currently in phase 2b development. Although imeglimin improves insulin sensitivity in humans, the molecular mechanisms are unknown. This study used a model of 16-week high-fat, high-sucrose diet (HFHSD) mice to characterize its antidiabetic effects. Six-week imeglimin treatment significantly decreased glycemia, restored normal glucose tolerance, and improved insulin sensitivity without modifying organs, body weights, and food intake. This was associated with an increase in insulin-stimulated protein kinase B phosphorylation in the liver and muscle. In liver mitochondria, imeglimin redirects substrate flows in favor of complex II, as illustrated by increased respiration with succinate and by the restoration of respiration with glutamate/malate back to control levels. In addition, imeglimin inhibits complex I and restores complex III activities, suggesting an increase in fatty acid oxidation, which is supported by an increase in hepatic 3-hydroxyacetyl-CoA dehydrogenase activity and acylcarnitine profile and the reduction of liver steatosis. Imeglimin also reduces reactive oxygen species production and increases mitochondrial DNA. Finally, imeglimin effects on mitochondrial phospholipid composition could participate in the benefit of imeglimin on mitochondrial function. In conclusion, imeglimin normalizes glucose tolerance and insulin sensitivity by preserving mitochondrial function from oxidative stress and favoring lipid oxidation in liver of HFHSD mice.
Collapse
Affiliation(s)
- Guillaume Vial
- INSERM U1060, Faculté de Médecine Lyon-Sud, Oullins, France Center for European Nutrition and Health, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France
| | | | - Nadia Bendridi
- INSERM U1060, Faculté de Médecine Lyon-Sud, Oullins, France
| | - Annie Durand
- INSERM U1060, Faculté de Médecine Lyon-Sud, Oullins, France
| | | | | | | | - Jean-Paul Pais de Barros
- Plateforme de lipidomique, Université de Bourgogne, Centre Hospitalier Universitaire le Bocage, Dijon, France
| | - Éric Fontaine
- INSERM U1055, Laboratoire de Bioénergétique Fondamentale et Appliquée (LBFA) et SFR Biologie Environnementale et Systémique (BEeSy), Grenoble, France Joseph Fourier University, Grenoble, France Grenoble University Hospital, Grenoble, France
| | - Cécile Acquaviva
- Service Maladies Héréditaires du Métabolisme, Centre de Biologie et Pathologie Est, Centre Hospitalier Universitaire de Lyon et UMR, Bron, France
| | | | | | - Hubert Vidal
- INSERM U1060, Faculté de Médecine Lyon-Sud, Oullins, France Center for European Nutrition and Health, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France Endocrinology, Diabetology, and Nutrition Service, Lyon-Sud Hospital, Hospices Civils de Lyon, Pierre-Bénite, France
| | - Jennifer Rieusset
- INSERM U1060, Faculté de Médecine Lyon-Sud, Oullins, France Center for European Nutrition and Health, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France Endocrinology, Diabetology, and Nutrition Service, Lyon-Sud Hospital, Hospices Civils de Lyon, Pierre-Bénite, France
| |
Collapse
|
44
|
Couëdelo L, Amara S, Lecomte M, Meugnier E, Monteil J, Fonseca L, Pineau G, Cansell M, Carrière F, Michalski MC, Vaysse C. Impact of various emulsifiers on ALA bioavailability and chylomicron synthesis through changes in gastrointestinal lipolysis. Food Funct 2015; 6:1726-35. [PMID: 25923344 DOI: 10.1039/c5fo00070j] [Citation(s) in RCA: 63] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Abstract
Formulating healthy food rich in omega 3 fatty acids requires prior knowledge of the parameters influencing their bioavailability and their metabolic fate. In this context, we studied the effects of various emulsifiers widely used in the food industry, on the gastrointestinal lipolysis of flaxseed oil emulsions in an in vitro model and on the intestinal absorption and lymphatic secretion of alpha-linolenic acid (ALA) in rats. In vitro data showed that the emulsification of flaxseed oil with soya lecithin improved the gastric lipolysis of the oil (+30%), while the presence of Tween 80 or of sodium caseinate decreased it (-80% and -40%, respectively). The in vivo data demonstrated that the intestinal absorption and the lymphatic secretion of ALA were improved with soya lecithin (Cmax = 24 mg mL(-1)) and reduced in the presence of sodium caseinate (Cmax = 7 mg mL(-1)) compared to unemulsified flaxseed oil (Cmax = 16 mg mL(-1)); Tween 80 had no effect. In addition, the synthesized chylomicrons were notably larger and more numerous with soya lecithin whereas they were smaller in the presence of sodium caseinate (p < 0.05). This study shows that the intestinal bioavailability of ALA was increased by the emulsification of flaxseed oil with soya lecithin via an improved lipolysis, favouring the intestinal absorption of ALA and the secretion of many large chylomicrons in lymph.
Collapse
Affiliation(s)
- L Couëdelo
- ITERG-ENMS, Université de Bordeaux, rue Léo Saignat, 33076 Bordeaux cedex, France.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Salvatore G, Bernoud-Hubac N, Bissay N, Debard C, Daira P, Meugnier E, Proamer F, Hanau D, Vidal H, Aricò M, Delprat C, Mahtouk K. Human monocyte-derived dendritic cells turn into foamy dendritic cells with IL-17A. J Lipid Res 2015; 56:1110-22. [PMID: 25833686 DOI: 10.1194/jlr.m054874] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2014] [Indexed: 02/07/2023] Open
Abstract
Interleukin 17A (IL-17A) is a proinflammatory cytokine involved in the pathogenesis of chronic inflammatory diseases. In the field of immunometabolism, we have studied the impact of IL-17A on the lipid metabolism of human in vitro-generated monocyte-derived dendritic cells (DCs). Microarrays and lipidomic analysis revealed an intense remodeling of lipid metabolism induced by IL-17A in DCs. IL-17A increased 2-12 times the amounts of phospholipids, cholesterol, triglycerides, and cholesteryl esters in DCs. Palmitic (16:0), stearic (18:0), and oleic (18:ln-9c) acid were the main fatty acid chains present in DCs. They were strongly increased in response to IL-17A while their relative proportion remained unchanged. Capture of extracellular lipids was the major mechanism of lipid droplet accumulation, visualized by electron microscopy and Oil Red O staining. Besides this foamy phenotype, IL-17A induced a mixed macrophage-DC phenotype and expression of the nuclear receptor NR1H3/liver X receptor-α, previously identified in the context of atherosclerosis as the master regulator of cholesterol homeostasis in macrophages. These IL-17A-treated DCs were as competent as untreated DCs to stimulate allogeneic naive T-cell proliferation. Following this first characterization of lipid-rich DCs, we propose to call these IL-17A-dependent cells "foamy DCs" and discuss the possible existence of foamy DCs in atherosclerosis, a metabolic and inflammatory disorder involving IL-17A.
Collapse
Affiliation(s)
- Giulia Salvatore
- CNRS, UMR5239, Laboratoire de Biologie Moléculaire de la Cellule, 69007 Lyon, France Ecole Normale Supérieure de Lyon, 69007 Lyon, France Université de Lyon, 69003 Lyon, France Université de Lyon 1, 69622 Villeurbanne, France Université de Florence, 50134 Florence, Italy
| | - Nathalie Bernoud-Hubac
- INSERM, U 1060 (CarMeN), INRA U1235, Institut Multidisciplinaire de Biochimie des Lipides, Institut National des Sciences Appliqués, 69621 Villeurbanne, France
| | - Nathalie Bissay
- CNRS, UMR5239, Laboratoire de Biologie Moléculaire de la Cellule, 69007 Lyon, France Ecole Normale Supérieure de Lyon, 69007 Lyon, France Université de Lyon, 69003 Lyon, France Université de Lyon 1, 69622 Villeurbanne, France
| | - Cyrille Debard
- INSERM, U 1060 (CarMeN), INRA U1235, Institut Multidisciplinaire de Biochimie des Lipides, Institut National des Sciences Appliqués, 69621 Villeurbanne, France
| | - Patricia Daira
- Functional Lipidomics Platform, Institut Multidisciplinaire de Biochimie des Lipides/Carnot Lisa, INSA-Lyon, 69622 Villeurbanne, France
| | - Emmanuelle Meugnier
- INSERM, U 1060 (CarMeN), INRA U1235, Institut Multidisciplinaire de Biochimie des Lipides, Institut National des Sciences Appliqués, 69621 Villeurbanne, France
| | - Fabienne Proamer
- Unité Mixte de Recherche Santé UMR S949, Institut National de la Santé et de la Recherche Médicale, 67000 Strasbourg, France Université de Strasbourg, 67400 Strasbourg, France Histocompatibility Laboratory, Etablissement Français du Sang-Alsace, 67000 Strasbourg, France
| | - Daniel Hanau
- Unité Mixte de Recherche Santé UMR S949, Institut National de la Santé et de la Recherche Médicale, 67000 Strasbourg, France Université de Strasbourg, 67400 Strasbourg, France Histocompatibility Laboratory, Etablissement Français du Sang-Alsace, 67000 Strasbourg, France
| | - Hubert Vidal
- INSERM, U 1060 (CarMeN), INRA U1235, Institut Multidisciplinaire de Biochimie des Lipides, Institut National des Sciences Appliqués, 69621 Villeurbanne, France
| | - Maurizio Aricò
- Istituto Toscano Tumori (I.T.T), 50139 Florence, Italy Azienda Sanitaria Provinciale 7, 97100 Ragusa, Italy
| | - Christine Delprat
- CNRS, UMR5239, Laboratoire de Biologie Moléculaire de la Cellule, 69007 Lyon, France Ecole Normale Supérieure de Lyon, 69007 Lyon, France Université de Lyon, 69003 Lyon, France Université de Lyon 1, 69622 Villeurbanne, France Institut Universitaire de France, 75005 Paris, France
| | - Karène Mahtouk
- CNRS, UMR5239, Laboratoire de Biologie Moléculaire de la Cellule, 69007 Lyon, France Ecole Normale Supérieure de Lyon, 69007 Lyon, France Université de Lyon, 69003 Lyon, France Université de Lyon 1, 69622 Villeurbanne, France
| |
Collapse
|
46
|
Aswad H, Forterre A, Wiklander OPB, Vial G, Danty-Berger E, Jalabert A, Lamazière A, Meugnier E, Pesenti S, Ott C, Chikh K, El-Andaloussi S, Vidal H, Lefai E, Rieusset J, Rome S. Exosomes participate in the alteration of muscle homeostasis during lipid-induced insulin resistance in mice. Diabetologia 2014; 57:2155-64. [PMID: 25073444 PMCID: PMC4153976 DOI: 10.1007/s00125-014-3337-2] [Citation(s) in RCA: 106] [Impact Index Per Article: 10.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/30/2014] [Accepted: 07/04/2014] [Indexed: 11/25/2022]
Abstract
AIMS/HYPOTHESIS Exosomes released from cells can transfer both functional proteins and RNAs between cells. In this study we tested the hypothesis that muscle cells might transmit specific signals during lipid-induced insulin resistance through the exosomal route. METHODS Exosomes were collected from quadriceps muscles of C57Bl/6 mice fed for 16 weeks with either a standard chow diet (SD) or an SD enriched with 20% palm oil (HP) and from C2C12 cells exposed to 0.5 mmol/l palmitate (EXO-Post Palm), oleate (EXO-Post Oleate) or BSA (EXO-Post BSA). RESULTS HP-fed mice were obese and insulin resistant and had altered insulin-induced Akt phosphorylation in skeletal muscle (SkM). They also had reduced expression of Myod1 and Myog and increased levels of Ccnd1 mRNA, indicating that palm oil had a deep impact on SkM homeostasis in addition to insulin resistance. HP-fed mouse SkM secreted more exosomes than SD-fed mouse SkM. This was reproduced in-vitro using C2C12 cells pre-treated with palmitate, the most abundant saturated fatty acid of palm oil. Exosomes from HP-fed mice, EXO-Post Palm and EXO-Post Oleate induced myoblast proliferation and modified the expressions of genes involved in the cell cycle and muscle differentiation but did not alter insulin-induced Akt phosphorylation. Lipidomic analyses showed that exosomes from palmitate-treated cells were enriched in palmitate, indicating that exosomes likely transfer the deleterious effect of palm oil between muscle cells by transferring lipids. Muscle exosomes were incorporated into various tissues in vivo, including the pancreas and liver, suggesting that SkM could transfer specific signals through the exosomal route to key metabolic tissues. CONCLUSIONS/INTERPRETATION Exosomes act as 'paracrine-like' signals and modify muscle homeostasis during high-fat diets.
Collapse
Affiliation(s)
- Hala Aswad
- CarMeN Laboratory (Inserm 1060, INRA 1397, INSA), University of Lyon, Faculté de Médecine Lyon-Sud, Oullins, France
| | - Alexis Forterre
- CarMeN Laboratory (Inserm 1060, INRA 1397, INSA), University of Lyon, Faculté de Médecine Lyon-Sud, Oullins, France
| | - Oscar P. B. Wiklander
- Department of Laboratory Medicine, Clinical Research Center, Karolinska Institutet, Karolinska University Hospital Huddinge, Huddinge, Sweden
| | - Guillaume Vial
- CarMeN Laboratory (Inserm 1060, INRA 1397, INSA), University of Lyon, Faculté de Médecine Lyon-Sud, Oullins, France
| | - Emmanuelle Danty-Berger
- CarMeN Laboratory (Inserm 1060, INRA 1397, INSA), University of Lyon, Faculté de Médecine Lyon-Sud, Oullins, France
| | - Audrey Jalabert
- CarMeN Laboratory (Inserm 1060, INRA 1397, INSA), University of Lyon, Faculté de Médecine Lyon-Sud, Oullins, France
| | - Antonin Lamazière
- Laboratory of Mass Spectrometry, Inserm ERL 1157, CNRS UMR 7203 LBM, Sorbonne Universités, UPMC University Paris 06, CHU Saint-Antoine, Paris, France
| | - Emmanuelle Meugnier
- CarMeN Laboratory (Inserm 1060, INRA 1397, INSA), University of Lyon, Faculté de Médecine Lyon-Sud, Oullins, France
| | - Sandra Pesenti
- CarMeN Laboratory (Inserm 1060, INRA 1397, INSA), University of Lyon, Faculté de Médecine Lyon-Sud, Oullins, France
| | - Catherine Ott
- Laboratoire Commun de Recherche HCL-bioMérieux Lyon-Sud, Oullins, France
| | - Karim Chikh
- CarMeN Laboratory (Inserm 1060, INRA 1397, INSA), University of Lyon, Faculté de Médecine Lyon-Sud, Oullins, France
| | - Samir El-Andaloussi
- Department of Laboratory Medicine, Clinical Research Center, Karolinska Institutet, Karolinska University Hospital Huddinge, Huddinge, Sweden
- Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK
| | - Hubert Vidal
- CarMeN Laboratory (Inserm 1060, INRA 1397, INSA), University of Lyon, Faculté de Médecine Lyon-Sud, Oullins, France
| | - Etienne Lefai
- CarMeN Laboratory (Inserm 1060, INRA 1397, INSA), University of Lyon, Faculté de Médecine Lyon-Sud, Oullins, France
| | - Jennifer Rieusset
- CarMeN Laboratory (Inserm 1060, INRA 1397, INSA), University of Lyon, Faculté de Médecine Lyon-Sud, Oullins, France
| | - Sophie Rome
- CarMeN Laboratory (Inserm 1060, INRA 1397, INSA), University of Lyon, Faculté de Médecine Lyon-Sud, Oullins, France
- CarMeN Laboratory (Inserm 1060, INRA 1397, INSA), University of Lyon, Faculté de Médecine Lyon-Sud, Oullins, France
| |
Collapse
|
47
|
Kroiss A, Vincent S, Decaussin-Petrucci M, Meugnier E, Viallet J, Ruffion A, Chalmel F, Samarut J, Allioli N. Androgen-regulated microRNA-135a decreases prostate cancer cell migration and invasion through downregulating ROCK1 and ROCK2. Oncogene 2014; 34:2846-55. [PMID: 25065599 DOI: 10.1038/onc.2014.222] [Citation(s) in RCA: 93] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2013] [Revised: 06/12/2014] [Accepted: 06/15/2014] [Indexed: 12/20/2022]
Abstract
Androgen signaling, via the androgen receptor (AR), is crucial in mediating prostate cancer (PCa) initiation and progression. Identifying new downstream effectors of the androgens/AR pathway will allow a better understanding of these mechanisms and could reveal novel biomarkers and/or therapeutic agents to improve the rate of patient survival. We compared the microRNA expression profiles in androgen-sensitive LNCaP cells stimulated or not with 1 nM R1881 by performing a high-throughput reverse transcriptase-quantitative PCR and found that miR-135a was upregulated. After androgen stimulation, we showed that AR directly activates the transcription of miR-135a2 gene by binding to an androgen response element in the promoter region. Our findings identify miR-135a as a novel effector in androgens/AR signaling. Using xenograft experiments in chick embryos and adult male mice, we showed that miR-135a overexpression decreases in vivo invasion abilities of prostate PC-3 cells. Through in vitro wound-healing migration and invasion assays, we demonstrated that this effect is mediated through downregulating ROCK1 and ROCK2 expression, two genes that we characterized as miR-135a direct target genes. In human surgical samples from prostatectomy, we observed that miR-135a expression was lower in tumoral compared with paired adjacent normal tissues, mainly in tumors classified with a high Gleason score (⩾8). Moreover, miR-135a expression is lower in invasive tumors, showing extraprostatic extension, as compared with intraprostatic localized tumors. In tumor relative to normal glands, we also showed a more frequently higher ROCK1 protein expression determined using a semi-quantitative immunohistochemistry analysis. Therefore, in tumor cells, the lower miR-135a expression could lead to a higher ROCK1 protein expression, which could explain their invasion abilities. The highlighted relationship between miR-135a expression level and the degree of disease aggressiveness suggests that miR-135a may be considered as a prognostic marker in human PCa.
Collapse
Affiliation(s)
- A Kroiss
- Université de Lyon, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Institut de Génomique Fonctionnelle de Lyon (IGFL), Lyon, France
| | - S Vincent
- Université de Lyon, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Institut de Génomique Fonctionnelle de Lyon (IGFL), Lyon, France
| | - M Decaussin-Petrucci
- 1] Université de Lyon, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Institut de Génomique Fonctionnelle de Lyon (IGFL), Lyon, France [2] Faculté de Médecine et de Maïeutique Lyon-Sud-Charles Mérieux, Université Claude Bernard Lyon 1, Pierre-Bénite, France [3] Service d'Anatomie et de Cytologie Pathologiques, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre-Bénite, France
| | - E Meugnier
- Laboratoire CarMen, INSERM U1060, INRA1362, Université Claude Bernard Lyon 1, Faculté de Médecine et de Maïeutique Lyon-Sud-Charles Mérieux, Oullins, France
| | - J Viallet
- In Ovo, Institut Albert Bonniot, CRI INSERM/UJF U823, Université de Grenoble, La Tronche Cedex, France
| | - A Ruffion
- 1] Université de Lyon, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Institut de Génomique Fonctionnelle de Lyon (IGFL), Lyon, France [2] Faculté de Médecine et de Maïeutique Lyon-Sud-Charles Mérieux, Université Claude Bernard Lyon 1, Pierre-Bénite, France [3] Service d'Urologie, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre-Bénite, France
| | - F Chalmel
- GERHM, INSERM U1085-Irset, Université Rennes 1, Rennes, France
| | - J Samarut
- 1] Université de Lyon, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Institut de Génomique Fonctionnelle de Lyon (IGFL), Lyon, France [2] Faculté de Médecine et de Maïeutique Lyon-Sud-Charles Mérieux, Université Claude Bernard Lyon 1, Pierre-Bénite, France [3] Service de Biochimie Biologie Moleculaire Sud, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre-Bénite, France
| | - N Allioli
- 1] Université de Lyon, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Institut de Génomique Fonctionnelle de Lyon (IGFL), Lyon, France [2] Institut des Sciences Pharmaceutiques et Biologiques (ISPB)-Faculté de Pharmacie de Lyon, Université Claude Bernard Lyon 1, Lyon, France
| |
Collapse
|
48
|
Seyssel K, Alligier M, Meugnier E, Chanseaume E, Loizon E, Canto C, Disse E, Lambert-Porcheron S, Brozek J, Blond E, Rieusset J, Morio B, Laville M, Vidal H. Regulation of energy metabolism and mitochondrial function in skeletal muscle during lipid overfeeding in healthy men. J Clin Endocrinol Metab 2014; 99:E1254-62. [PMID: 24684464 DOI: 10.1210/jc.2013-4379] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
CONTEXT/OBJECTIVE The aim of this study was to evaluate the regulation of the fuel partitioning and energy metabolism in skeletal muscle during lipid overfeeding in healthy men. Design/Participants/Intervention: Thirty-nine healthy volunteers were overfed for 56 days with a high-fat diet (3180 kJ/d). Energy metabolism (indirect calorimetry) was characterized in the fasting state and during a test meal before and at the end of the diet. Skeletal muscle biopsies were taken at day 0 and day 56. MAIN OUTCOME MEASURES Change in gene expression, mitochondrial respiration, nicotinamide adenine dinucleotide (NAD(+)) content, and acetylation of peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) in skeletal muscle was measured. RESULTS Overfeeding increased body weight (+2.6 kg) and fat mass concomitantly with a shift in the use of substrates as energy fuel toward preferential oxidation of carbohydrates instead of lipids. Changes in lipid metabolic gene expression supported this observation, with a reduction in pyruvate dehydrogenase kinase 4 expression that could be the consequences of decreased NAD(+) concentration and reduced deacetylase activity of the sirtuins, as supported by hyperacetylation of PGC-1α after overfeeding. Interestingly, this reduction of the sirtuin PGC-1α pathway was associated with increased mitochondrial gene expression and higher respiration rate under these conditions. CONCLUSION Adaptation to lipid overfeeding and regulation of fuel partitioning in human muscle appear to rely on a dissociation between the regulatory functions of the sirtuin-PGC-1α pathway on fatty acid oxidation and on mitochondrial regulation. This may facilitate lipid storage during a period of positive energy balance while maintaining mitochondrial functions and oxidative capacities.
Collapse
Affiliation(s)
- K Seyssel
- INSERM Unité Mixte de Recherche 1060 (K.S., M.A., E.M., E.L., E.D., E.B., J.R., M.L., H.V.), Laboratoires CarMeN et Centre Européen pour la Nutrition et la Santé, Université Lyon 1, F-69600 Oullins, France; Centre de Recherche en Nutrition Humaine Rhône-Alpes (K.S., M.A., E.D., S.L.-P., E.B., M.L., H.V.), Centre Hospitalier Lyon-Sud, F-69310 Pierre Bénite, France; Institut National de la Recherche Agronomique Unité 1235 (E.M., J.R., M.L., H.V.), F-69600 Oullins, France; Institut National de la Recherche Agronomique Unité Mixte de Recherche 1019 (E.C., B.M.), Unité de Nutrition Humaine and Centre de Recherche en Nutrition Humaine Auvergne, Université d'Auvergne, F-63000 Clermont-Ferrand, France; Laboratory of Integrative and Systems Physiology (C.C.), Ecole Polytechnique Fédérale de Lausanne, School of Life Sciences - Institute of Bioengineering, CH-1015 Lausanne, Switzerland; and Genfit (J.B.), F-59120 Loos, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Seyssel K, Alligier M, Meugnier E, Chanseaume E, Canto C, Disse E, Lambert-Porcheron S, Brozek J, Blond E, Rieusset J, Morio B, Laville M, Vidal H. O03 La régulation du métabolisme énergétique dans le muscle squelettique au cours d’une surnutrition hyperlipidique chez l’homme sain. NUTR CLIN METAB 2013. [DOI: 10.1016/s0985-0562(13)70275-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
50
|
Hokayem M, Blond E, Vidal H, Lambert K, Meugnier E, Feillet-Coudray C, Coudray C, Pesenti S, Luyton C, Lambert-Porcheron S, Sauvinet V, Fedou C, Brun JF, Rieusset J, Bisbal C, Sultan A, Mercier J, Goudable J, Dupuy AM, Cristol JP, Laville M, Avignon A. Grape polyphenols prevent fructose-induced oxidative stress and insulin resistance in first-degree relatives of type 2 diabetic patients. Diabetes Care 2013; 36:1454-61. [PMID: 23275372 PMCID: PMC3661802 DOI: 10.2337/dc12-1652] [Citation(s) in RCA: 101] [Impact Index Per Article: 9.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
OBJECTIVE To assess the clinical efficacy of nutritional amounts of grape polyphenols (PPs) in counteracting the metabolic alterations of high-fructose diet, including oxidative stress and insulin resistance (IR), in healthy volunteers with high metabolic risk. RESEARCH DESIGN AND METHODS Thirty-eight healthy overweight/obese first-degree relatives of type 2 diabetic patients (18 men and 20 women) were randomized in a double-blind controlled trial between a grape PP (2 g/day) and a placebo (PCB) group. Subjects were investigated at baseline and after 8 and 9 weeks of supplementation, the last 6 days of which they all received 3 g/kg fat-free mass/day of fructose. The primary end point was the protective effect of grape PPs on fructose-induced IR. RESULTS In the PCB group, fructose induced 1) a 20% decrease in hepatic insulin sensitivity index (P < 0.05) and an 11% decrease in glucose infusion rate (P < 0.05) as evaluated during a two-step hyperinsulinemic-euglycemic clamp, 2) an increase in systemic (urinary F2-isoprostanes) and muscle (thiobarbituric acid-reactive substances and protein carbonylation) oxidative stress (P < 0.05), and 3) a downregulation of mitochondrial genes and decreased mitochondrial respiration (P < 0.05). All the deleterious effects of fructose were fully blunted by grape PP supplementation. Antioxidative defenses, inflammatory markers, and main adipokines were affected neither by fructose nor by grape PPs. CONCLUSIONS A natural mixture of grape PPs at nutritional doses efficiently prevents fructose-induced oxidative stress and IR. The current interest in grape PP ingredients and products by the global food and nutrition industries could well make them a stepping-stone of preventive nutrition.
Collapse
Affiliation(s)
- Marie Hokayem
- INSERM U1046, Physiologie & Médecine Expérimentale du Cœur et des Muscles, Montpellier, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|